AHFS Drug Reassignments
The following describes drug assignments and changes to the AHFS Pharmacologic-Therapeutic Classification©. This is only a partial listing of the AHFS classification system. The full classification, along with a list of drugs covered in AHFS DI and their corresponding classes, is available in the print edition of AHFS and electronically as a dataset that can be licensed. Reproduction, storage on a retrieval system, or transmission of this material or any part thereof in any form or by any means without the express written permission of the American Society of Health-System Pharmacists is prohibited.
Please contact us at ahfs@ashp.org if you have any questions.
AHFS Drug Reassignments
| Drug Name | Active Ingredients | Change Date | Old AHFS Class | New AHFS Class |
|---|---|---|---|---|
| Vanrafia | atrasentan | 06/23/2025 | 48:48.12 - Endothelin receptor antagonists | 92:48 - IgA nephropathy |
| Filspari® | sparsentan | 06/23/2025 | 48:48.12 - Endothelin receptor antagonists; 24:32.92 - Renin-Angiotensin-Aldosterone System Inhibitors, Miscellaneous | 92:48 - IgA nephropathy; 24:32.92 - Renin-Angiotensin-Aldosterone System Inhibitors, Miscellaneous |
| Tryngolza | olezarsen | 06/23/2025 | 24:06.92 - Antilipemic Agents, Miscellaneous | 24:06.92 - Antilipemic Agents, Miscellaneous; 92:18 - Antisense Oligonucleotides |
| Lutathera® | lutetium Lu-177 dotatate | 04/07/2025 | 10:00 - Antineoplastic Agents | 10:00 - Antineoplastic Agents; 78:00 - Radioactive Agents |
| Izervay | Avacincaptad Pegol | 04/02/2025 | 52:92 - EENT Drugs, Miscellaneous | 52:44 - Macular Degeneration Agents; 90:20 - Complement Inhibitor Agents |
| Syfovre | Pegcetacoplan (Geographic Atrophy) | 04/02/2025 | 52:92 - EENT Drugs, Miscellaneous | 52:44 - Macular Degeneration Agents; 90:20 - Complement Inhibitor Agents |
| Aggrenox; Persantine | Dipyridamole | 02/06/2025 | 36:18 - Cardiac Function | 20:12.18 - Platelet-aggregation Inhibitors; 36:18 - Cardiac Function |
| N/A | Benzodiazepines General Statement | 11/26/2024 | 28:24.08 - Benzodiazepines; 28:12.08 - Benzodiazepines | 28:24.08 - Benzodiazepines; 28:12.08 - Benzodiazepines |
| Orabase-B; Cepacol; Cetacaine; Dermoplast | Benzocaine (EENT) | 10/29/2024 | 52:16 - Local Anesthetics | 52:16 - Local Anesthetics; 84:08 - Antipruritics and Local Anesthetics |
| Neosporin Ophthalmic Ointment | Bacitracin (EENT) | 10/29/2024 | 52:04.04 - Antibacterials; 84:04.04 - Antibacterials | 52:04.04 - Antibacterials; 84:04.04 - Antibacterials; 8:12.28.08 - Bacitracins |
| Neosporin | Bacitracin (Topical) | 10/29/2024 | 84:04.04 - Antibacterials; 52:04.04 - Antibacterials | 84:04.04 - Antibacterials; 52:04.04 - Antibacterials; 8:12.28.08 - Bacitracins |
| Lotensin; Lotrel | Benazepril | 10/29/2024 | 24:32.04 - Angiotensin-Converting Enzyme Inhibitors; 24:08.44.04 - Angiotensin-Converting Enzyme Inhibitors | 24:32.04 - Angiotensin-Converting Enzyme Inhibitors |
| Rylaze | Asparaginase Erwinia Chrysanthemi (Recombinant) | 10/29/2024 | 10:00 - Antineoplastic Agents | 10:00 - Antineoplastic Agents; 44:00 - Enzymes |
| Brovana | Arformoterol | 10/29/2024 | 12:12.08.12 - Selective beta-2-Adrenergic Agonists | 12:12.08.12 - Selective beta-2-Adrenergic Agonists; 48:12.04.12 - Selective beta-2-Adrenergic Agonists |
| Otezla; Otezla Starter Pack | Apremilast | 10/29/2024 | 90:24.24.92 - Phosphodiesterase-4 Inhibitors, Miscellaneous; 92:20 - Immunomodulatory Agents; 84:92 - Skin and Mucous Membrane Agents, Miscellaneous | 90:24.24.92 - Phosphodiesterase-4 Inhibitors, Miscellaneous |
| Campath | Alemtuzumab | 10/29/2024 | 10:00 - Antineoplastic Agents; 92:20 - Immunomodulatory Agents; 90:04.04 - Monoclonal Antibodies | 10:00 - Antineoplastic Agents; 90:04.04 - Monoclonal Antibodies |
| Duaklir Pressair; Tudorza Pressair | Aclidinium | 10/29/2024 | 12:08.08 - Antimuscarinics/Antispasmodics | 12:08.08 - Antimuscarinics/Antispasmodics; 48:12.08 - Anticholinergic Agents |
| Dysport | AbobotulinumtoxinA | 10/29/2024 | 12:20.20.24 - Botulinum toxins; 12:20.92 - Skeletal Muscle Relaxants, Miscellaneous | 12:20.20.24 - Botulinum toxins |
| Orencia | Abatacept | 10/29/2024 | 90:24.92 - Disease-modifying Antirheumatic Drugs, Miscellaneous; 92:20 - Immunomodulatory Agents | 90:24.92 - Disease-modifying Antirheumatic Drugs, Miscellaneous |
| LamISIL AT; LamISIL AT Continuous Spray; LamISIL AT Spray Pump | Terbinafine | 10/29/2024 | 84:04.08.04 - Allylamines | 84:04.08.04 - Allylamines; 8:14.04 - Allylamines |
| Advicor; Niacor; Niaspan | Niacin | 10/29/2024 | 24:06.92 - Antilipemic Agents, Miscellaneous | 24:06.92 - Antilipemic Agents, Miscellaneous; 88:08 - Vitamin B Complex |
| Bactine First Aid Antibiotic Plus Anesthetic; Neosporin; Neosporin G.U. Irrigant; Spectrocin Plus; Triple Antibiotic Extra | Neomycin (Topical) | 10/29/2024 | 84:04.04 - Antibacterials | 84:04.04 - Antibacterials; 8:12.02 - Aminoglycosides; 52:04.04 - Antibacterials |
| Calan; Covera-HS; Isoptin SR; Tarka; Verelan; Verelan PM | Verapamil | 10/29/2024 | 24:04.04.24 - Class IV Antiarrhythmics; 24:28 - Calcium-Channel Blocking Agents | 24:04.04.24 - Class IV Antiarrhythmics |
| Tyrvaya | Varenicline (nasal) | 10/29/2024 | 52:92 - EENT Drugs, Miscellaneous | 52:92 - EENT Drugs, Miscellaneous; 12:02 - Smoking Cessation Agents |
| Diovan; Exforge | Valsartan | 10/29/2024 | 24:32.08 - Angiotensin II Receptor Antagonists; 24:08.92 - Vasodilating Agents, Miscellaneous | 24:32.08 - Angiotensin II Receptor Antagonists |
| Vistogard; Xuriden | Uridine Triacetate | 10/29/2024 | 91:04.32 - Fluoropyrimidine antidote; 92:92 - Other Miscellaneous Therapeutic Agents | 91:04.32 - Fluoropyrimidine antidote |
| Carbamide | Urea | 10/29/2024 | 40:28.12 - Osmotic Diuretics | 40:28.12 - Osmotic Diuretics; 24:36.12 - Osmotic Diuretics; 52:40.24 - Osmotic Agents; 84:28 - Keratolytic Agents |
| Aqua Care; Carmol; Gordon's Urea; Nutraplus; Rea-Lo; Ultra Mide; Ureacin | Urea | 10/29/2024 | 84:28 - Keratolytic Agents | 84:28 - Keratolytic Agents; 24:36.12 - Osmotic Diuretics; 40:28.12 - Osmotic Diuretics; 52:40.24 - Osmotic Agents |
| Anoro Ellipta | Umeclidinium Bromide and Vilanterol Trifenatate | 10/29/2024 | 12:08.08 - Antimuscarinics/Antispasmodics | 12:08.08 - Antimuscarinics/Antispasmodics; 12:12.08.12 - Selective beta-2-Adrenergic Agonists |
| Incruse Ellipta; Trelegy Ellipta | Umeclidinium | 10/29/2024 | 12:08.08 - Antimuscarinics/Antispasmodics | 12:08.08 - Antimuscarinics/Antispasmodics; 48:12.08 - Anticholinergic Agents |
| Trihexyphenidyl | 10/29/2024 | 28:36.08 - Anticholinergic Agents | 28:36.08 - Anticholinergic Agents; 12:08.04 - Antiparkinsonian Agents | |
| Aristocort; Flutex; Kenalog; Myco II; Mytrex; N.T.A. Cream; NGT; Triacet; Tri-Statin II | Triamcinolone | 10/29/2024 | 84:06.08 - Corticosteroids | 84:06.08 - Corticosteroids; 48:10.08 - Corticosteroids; 52:08.08 - Corticosteroids; 68:04 - Adrenals |
| Avita; Renova Emollient; Retin-A; Retin-A Micro | Tretinoin | 10/29/2024 | 84:16 - Cell Stimulants and Proliferants | 84:16 - Cell Stimulants and Proliferants; 10:00 - Antineoplastic Agents |
| Lysteda; Cyklokapron | Tranexamic acid | 10/29/2024 | 20:28.16 - Hemostatics | |
| Mavik; Tarka | Trandolapril | 10/29/2024 | 24:32.04 - Angiotensin-Converting Enzyme Inhibitors; 24:08.92 - Vasodilating Agents, Miscellaneous | 24:32.04 - Angiotensin-Converting Enzyme Inhibitors |
| AK-Tob; TobraDex; Tobrex; Zylet | Tobramycin | 10/29/2024 | 52:04.04 - Antibacterials | 52:04.04 - Antibacterials; 8:12.02 - Aminoglycosides |
| Mounjaro | Tirzepatide | 10/29/2024 | 68:20.06 - Incretin Mimetics | 68:20.06 - Incretin Mimetics; 28:20.08.92 - Anorexigenic Agents, Miscellaneous |
| Betimol; Cosopt Ocumeter Plus | Timolol | 10/29/2024 | 52:40.08 - beta-Adrenergic Blocking Agents | 52:40.08 - beta-Adrenergic Blocking Agents; 24:20 - beta-Adrenergic Blocking Agents; 24:04.04.16 - Class II Antiarrhythmics; 12:16.08.04 - Non-selective beta-Adrenergic Blocking Agents; 28:32.92 - Antimigraine Agents, Miscellaneous; |
| Thalomid | Thalidomide | 10/29/2024 | 92:20 - Immunomodulatory Agents | 92:20 - Immunomodulatory Agents; 10:00 - Antineoplastic Agents |
| Tezspire | Tezepelumab-ekko | 10/29/2024 | 48:10.20 - Interleukin Antagonists; 8:18.24 - Monoclonal Antibodies | 48:10.20 - Interleukin Antagonists |
| Symdeko | Tezacaftor and Ivacaftor | 10/29/2024 | 48:14.04 - Cystic Fibrosis Transmembrane Conductance Regulator Correctors | 48:14.04 - Cystic Fibrosis Transmembrane Conductance Regulator Correctors; 48:14.12 - Cystic Fibrosis Transmembrane Conductance Regulator Potentiators |
| Helidac Therapy; Pylera; Sumycin | Tetracycline (systemic) | 10/29/2024 | 8:12.24 - Tetracyclines; 8:30.08 - Antimalarials | 8:12.24 - Tetracyclines; 8:30.08 - Antimalarials; 56:28 - Antiulcer Agents and Acid Suppressants; 84:04.04 - Antibacterials |
| Tetracycline | 10/29/2024 | 84:04.04 - Antibacterials | 84:04.04 - Antibacterials; 8:12.24 - Tetracyclines; 8:30.08 - Antimalarials; 56:28 - Antiulcer Agents and Acid Suppressants | |
| Altacaine; Tetcaine; Tetravisc | Tetracaine | 10/29/2024 | 52:16 - Local Anesthetics | 52:16 - Local Anesthetics; 72:00 - Local Anesthetics |
| Androderm; AndroGel; Aveed; Axiron; Delatestryl; Depo-Testosterone; Fortesta; Jatenzo; Natesto; Striant; Testim; Testopel; Vogelxo; Tlando; Xyosted | Testosterone | 10/29/2024 | 68:08 - Androgens | 68:08 - Androgens; 68:18.04 - Antigonadotropins |
| Micardis; Micardis HCT; Twynsta | Telmisartan | 10/29/2024 | 24:32.08 - Angiotensin II Receptor Antagonists; 24:08.44.08 - Angiotensin II Receptor Antagonists | 24:32.08 - Angiotensin II Receptor Antagonists |
| Protopic | Tacrolimus | 10/29/2024 | 84:06.28 - Immunomodulatory Agents | 84:06.28 - Immunomodulatory Agents; 90:28.28.92 - Calcineurin Inhibitors, Miscellaneous |
| Astagraf; Envarsus; Prograf | Tacrolimus | 10/29/2024 | 90:28.28.92 - Calcineurin Inhibitors, Miscellaneous | 90:28.28.92 - Calcineurin Inhibitors, Miscellaneous; 84:06.28 - Immunomodulatory Agents |
| Aldactazide; Aldactone | Spironolactone | 10/29/2024 | 24:32.20.08 - Steroidal Mineralocorticoid Receptor Antagonists; 24:36.16 - Potassium-sparing Diuretics | 24:32.20.08 - Steroidal Mineralocorticoid Receptor Antagonists; 24:36.16 - Potassium-sparing Diuretics; 40:28.16 - Potassium-sparing Diuretics |
| Filspari | Sparsentan | 10/29/2024 | 48:48.12 - Endothelin receptor antagonists | 48:48.12 - Endothelin receptor antagonists; 24:32.92 - Renin-Angiotensin-Aldosterone System Inhibitors, Miscellaneous |
| Vosevi | Sofosbuvir, Velpatasvir, Voxilaprevir | 10/29/2024 | 8:18.40.16 - HCV Polymerase Inhibitors | 8:18.40.16 - HCV Polymerase Inhibitors; 8:18.40.20 - HCV Protease Inhibitors; 8:18.40.24 - HCV Replication Complex Inhibitors |
| Nithiodote | Sodium Thiosulfate | 10/29/2024 | 91:04.24 - Cyanide antidotes | 91:04.24 - Cyanide antidotes; 84:04.08.92 - Antifungals, Miscellaneous |
| Hyftor | Sirolimus | 10/29/2024 | 84:06.28 - Immunomodulatory Agents | 84:06.28 - Immunomodulatory Agents; 90:28.24.92 - mTOR Inhibitors, Miscellaneous |
| Viagra | Sildenafil | 10/29/2024 | 24:08.12 - Phosphodiesterase Type 5 Inhibitors | 24:08.12 - Phosphodiesterase Type 5 Inhibitors; 48:48.24 - Phosphodiesterase Type 5 Inhibitors |
| Liqrev; Revatio | Sildenafil Citrate (Pulmonary Hypertension) | 10/29/2024 | 48:48.24 - Phosphodiesterase Type 5 Inhibitors | 48:48.24 - Phosphodiesterase Type 5 Inhibitors; 24:08.12 - Phosphodiesterase Type 5 Inhibitors |
| Imcivree | Setmelanotide | 10/29/2024 | 68:48 - Melanocortin Receptor Agonists; 28:92 - Central Nervous System Agents, Miscellaneous | 68:48 - Melanocortin Receptor Agonists |
| Ozempic; Rybelsus | Semaglutide | 10/29/2024 | 68:20.06 - Incretin Mimetics | 68:20.06 - Incretin Mimetics; 28:20.08.92 - Anorexigenic Agents, Miscellaneous |
| Isopto Hyoscine; Murocoll-2 | Scopolamine | 10/29/2024 | 52:24 - Mydriatics | 52:24 - Mydriatics; 12:08.08 - Antimuscarinics/Antispasmodics; 56:22.92 - Antiemetics, Miscellaneous |
| Salicylates General Statement | 10/29/2024 | 28:08.04.24 - Salicylates; 28:32.92 - Antimigraine Agents, Miscellaneous | 28:08.04.24 - Salicylates | |
| Opzelura | Ruxolitinib Phosphate | 10/29/2024 | 84:06.16 - Janus Kinase Inhibitors | 84:06.16 - Janus Kinase Inhibitors; 10:00 - Antineoplastic Agents |
| Myobloc | RimabotulinumtoxinB | 10/29/2024 | 12:20.20.24 - Botulinum toxins; 12:20.92 - Skeletal Muscle Relaxants, Miscellaneous | 12:20.20.24 - Botulinum toxins |
| Yupelri | Revefenacin | 10/29/2024 | 12:08.08 - Antimuscarinics/Antispasmodics | 12:08.08 - Antimuscarinics/Antispasmodics; 48:12.08 - Anticholinergic Agents |
| Altace | Ramipril | 10/29/2024 | 24:32.04 - Angiotensin-Converting Enzyme Inhibitors; 24:08.92 - Vasodilating Agents, Miscellaneous | 24:32.04 - Angiotensin-Converting Enzyme Inhibitors |
| Phenadoz; Phenergan; Promethegan | Promethazine | 10/29/2024 | 28:24.92 - Anxiolytics, Sedatives, and Hypnotics; Miscellaneous; 56:22.92 - Antiemetics, Miscellaneous | 28:24.92 - Anxiolytics, Sedatives, and Hypnotics; Miscellaneous; 56:22.92 - Antiemetics, Miscellaneous; 56:22.12 - Dopamine Receptor Antagonists |
| Fallback Solo; Implanon; Kyleena; Liletta; Micronor; Mirena; Nexplanon; Skyla; Slynd | Progestins | 10/29/2024 | 68:12 - Contraceptives; 68:32 - Progestins | 68:12 - Contraceptives; 68:32 - Progestins; 68:18.04 - Antigonadotropins |
| Salagen | Pilocarpine | 10/29/2024 | 12:04 - Parasympathomimetic (Cholinergic) Agents | 12:04 - Parasympathomimetic (Cholinergic) Agents; 52:40.20 - Miotics |
| Children's Sudafed PE Cold & Cough; Preparation H; Sudafed PE Cold + Cough Caplets; Vazculep | Phenylephrine | 10/29/2024 | 12:12.04 - alpha-Adrenergic Agonists | 12:12.04 - alpha-Adrenergic Agonists; 52:32 - Vasoconstrictors; 52:24 - Mydriatics |
| Phentolamine Mesylate for Injection | Phentolamine | 10/29/2024 | 12:16.04.04 - Non-selective alpha-Adrenergic Blocking Agents; 24:08.92 - Vasodilating Agents, Miscellaneous | 12:16.04.04 - Non-selective alpha-Adrenergic Blocking Agents |
| Dibenzyline | Phenoxybenzamine | 10/29/2024 | 12:16.04.04 - Non-selective alpha-Adrenergic Blocking Agents; 24:08.92 - Vasodilating Agents, Miscellaneous | 12:16.04.04 - Non-selective alpha-Adrenergic Blocking Agents |
| Aceon; Prestalia | Perindopril | 10/29/2024 | 24:32.04 - Angiotensin-Converting Enzyme Inhibitors; 24:08.44.04 - Angiotensin-Converting Enzyme Inhibitors | 24:32.04 - Angiotensin-Converting Enzyme Inhibitors |
| Pegasys; PegIntron | Peginterferon Alfa (Antiviral) | 10/29/2024 | 8:18.20 - Interferons; 92:20 - Immunomodulatory Agents; 10:00 - Antineoplastic Agents | 8:18.20 - Interferons; 90:04.12 - Interferons; 10:00 - Antineoplastic Agents |
| N/A | Opium | 10/29/2024 | 28:08.08 - Opioid Agonists | 28:08.08 - Opioid Agonists; 56:08 - Antidiarrhea Agents |
| N/A | Opioid Agonists General Statement | 10/29/2024 | 28:08.08 - Opioid Agonists; 28:32.92 - Antimigraine Agents, Miscellaneous | 28:08.08 - Opioid Agonists |
| Botox; Botox Cosmetic | OnabotulinumtoxinA | 10/29/2024 | 12:20.20.24 - Botulinum toxins; 12:20.92 - Skeletal Muscle Relaxants, Miscellaneous | 12:20.20.24 - Botulinum toxins |
| Stiolto Respimat; Striverdi Respimat | Olodaterol | 10/29/2024 | 12:12.08.12 - Selective beta-2-Adrenergic Agonists | 12:12.08.12 - Selective beta-2-Adrenergic Agonists; 48:12.04.12 - Selective beta-2-Adrenergic Agonists |
| Azor; Benicar; Tribenzor | Olmesartan | 10/29/2024 | 24:32.08 - Angiotensin II Receptor Antagonists; 24:08.44.08 - Angiotensin II Receptor Antagonists | 24:32.08 - Angiotensin II Receptor Antagonists |
| Symbyax; ZyPREXA | OLANZapine | 10/29/2024 | 28:16.08.04 - Atypical Antipsychotics; 28:28 - Antimanic Agents | 28:16.08.04 - Atypical Antipsychotics; 28:28 - Antimanic Agents; 56:22.92 - Antiemetics, Miscellaneous |
| Mycostatin; Mykacet; Nystat-Rx; Nystop; Pedi-Dri | Nystatin | 10/29/2024 | 84:04.08.28 - Polyenes | 84:04.08.28 - Polyenes; 8:14.28 - Polyenes |
| Rectiv | Nitroglycerin | 10/29/2024 | 84:24.12 - Basic Ointments and Protectants | 84:24.12 - Basic Ointments and Protectants; 24:08.08 - Nitrates and Nitrites |
| Sular | Nisoldipine | 10/29/2024 | 24:28.08 - Dihydropyridines; 24:08.92 - Vasodilating Agents, Miscellaneous | 24:28.08 - Dihydropyridines |
| Nimotop | niMODipine | 10/29/2024 | 24:28.08 - Dihydropyridines; 24:08.92 - Vasodilating Agents, Miscellaneous | 24:28.08 - Dihydropyridines |
| Cardene I.V.; Cardene SR | niCARdipine | 10/29/2024 | 24:28.08 - Dihydropyridines; 24:08.92 - Vasodilating Agents, Miscellaneous | 24:28.08 - Dihydropyridines |
| Slo-Niacin | Niacin/Niacinamide | 10/29/2024 | 88:08 - Vitamin B Complex | 88:08 - Vitamin B Complex; 24:06.92 - Antilipemic Agents, Miscellaneous |
| Bunavail; Cassipa; Evzio; Narcan; Suboxone; Zubsolv | Naloxone | 10/29/2024 | 28:10 - Opioid Antagonists | 28:10 - Opioid Antagonists; 91:00 - Antidote Therapeutics |
| Moxeza; Vigamox | Moxifloxacin | 10/29/2024 | 52:04.04 - Antibacterials | 52:04.04 - Antibacterials; 8:12.18 - Quinolones |
| Bafiertam | Monomethyl fumarate | 10/29/2024 | 92:20 - Immunomodulatory Agents | 90:04.08 - Fumarates |
| Elocon | Mometasone | 10/29/2024 | 84:06.08 - Corticosteroids | 84:06.08 - Corticosteroids; 68:04 - Adrenals; 48:10.08 - Corticosteroids; 52:08.08 - Corticosteroids |
| Moexipril | 10/29/2024 | 24:32.04 - Angiotensin-Converting Enzyme Inhibitors; 24:08.92 - Vasodilating Agents, Miscellaneous | 24:32.04 - Angiotensin-Converting Enzyme Inhibitors | |
| Dynacin; Minocin; Minolira; Solodyn; Ximino | Minocycline | 10/29/2024 | 8:12.24 - Tetracyclines; 8:30.08 - Antimalarials | 8:12.24 - Tetracyclines; 8:30.08 - Antimalarials; 84:04.04 - Antibacterials; 52:04.04 - Antibacterials |
| Amzeeq; Zilxi | Minocycline (Topical) | 10/29/2024 | 84:04.04 - Antibacterials | 84:04.04 - Antibacterials; 8:12.24 - Tetracyclines; 8:30.08 - Antimalarials; 52:04.04 - Antibacterials |
| Arestin | Minocycline (EENT) | 10/29/2024 | 52:04.04 - Antibacterials | 52:04.04 - Antibacterials; 8:12.24 - Tetracyclines; 8:30.08 - Antimalarials; 84:04.04 - Antibacterials |
| Osmitrol; Osmitrol 5% | Mannitol (Diagnostic) | 10/29/2024 | 36:40 - Kidney Function | 36:40 - Kidney Function; 24:36.12 - Osmotic Diuretics; 40:28.12 - Osmotic Diuretics; 40:36 - Irrigating Solutions; 52:40.24 - Osmotic Agents |
| Magnesium Sulfate Injection; Magnesium Sulfate in 5% Dextrose Injection | Magnesium Sulfate | 10/29/2024 | 28:12.92 - Anticonvulsants, Miscellaneous; 24:04.04.92 - Antiarrhythmics, Miscellaneous | 28:12.92 - Anticonvulsants, Miscellaneous; 24:04.04.92 - Antiarrhythmics, Miscellaneous; 91:00 - Antidote Therapeutics |
| Lutathera | Lutetium Lu-177 Dotatate | 10/29/2024 | 10:00 - Antineoplastic Agents; 78:00 - Radioactive Agents | 10:00 - Antineoplastic Agents |
| Reblozyl | luspatercept | 10/29/2024 | 20:16 - Hematopoietic Agents | 20:16 - Hematopoietic Agents; 20:04 - Antianemia Drugs |
| Prinivil; Prinzide; Zestoretic; Zestril | Lisinopril | 10/29/2024 | 24:32.04 - Angiotensin-Converting Enzyme Inhibitors; 24:08.92 - Vasodilating Agents, Miscellaneous | 24:32.04 - Angiotensin-Converting Enzyme Inhibitors |
| levoFLOXacin (EENT) | 10/29/2024 | 52:04.04 - Antibacterials | 52:04.04 - Antibacterials; 8:12.18 - Quinolones | |
| Arava | Leflunomide | 10/29/2024 | 90:24.04 - Monocarboxylic Acid Amide Agents; 92:20 - Immunomodulatory Agents | 90:24.04 - Monocarboxylic Acid Amide Agents |
| Acular; Acular LS; Acular PF | Ketorolac | 10/29/2024 | 52:08.20 - Nonsteroidal Anti-inflammatory Agents | 52:08.20 - Nonsteroidal Anti-inflammatory Agents; 28:08.04.04 - Reversible COX-1/COX-2 Inhibitors |
| Extina; Ketoconazole Cream; Nizoral; Nizoral A-D; Xolegel | Ketoconazole | 10/29/2024 | 84:04.08.08 - Azoles | 84:04.08.08 - Azoles; 8:14.08 - Azoles |
| Ketalar | Ketamine | 10/29/2024 | 28:04.08 - Non-barbiturates | 28:04.08 - Non-barbiturates; 28:16.04.92 - Antidepressants, Miscellaneous |
| Azedra | Iobenguane I-131 | 10/29/2024 | 10:00 - Antineoplastic Agents; 78:00 - Radioactive Agents; 36:68 - Roentgenography | 10:00 - Antineoplastic Agents |
| Xeomin | IncobotulinumtoxinA | 10/29/2024 | 12:20.20.24 - Botulinum toxins; 12:20.92 - Skeletal Muscle Relaxants, Miscellaneous | 12:20.20.24 - Botulinum toxins |
| Anaspaz; Cystospaz; Levbid; Levsin; NuLev; Symax DuoTab; Symax FasTab; Symax SL; Symax SR | Hyoscyamine | 10/29/2024 | 12:08.08 - Antimuscarinics/Antispasmodics; 91:00 - Antidote Therapeutics | 12:08.08 - Antimuscarinics/Antispasmodics; 91:00 - Antidote Therapeutics; 48:12.08 - Anticholinergic Agents |
| Plaquenil | Hydroxychloroquine | 10/29/2024 | 8:30.08 - Antimalarials; 92:20 - Immunomodulatory Agents | 8:30.08 - Antimalarials; 92:20 - Immunomodulatory Agents; 90:24 - Disease-modifying Antirheumatic Drugs |
| Bevespi; Cuvposa; Glyrx-PF; Lonhala, Robinul, Seebri, Utibron | Glycopyrrolate | 10/29/2024 | 12:08.08 - Antimuscarinics/Antispasmodics; 84:12 - Astringents | 12:08.08 - Antimuscarinics/Antispasmodics; 84:12 - Astringents; 48:12.08 - Anticholinergic Agents |
| Garamycin Cream; Garamycin Ointment | Gentamicin Sulfate (Topical) | 10/29/2024 | 84:04.04 - Antibacterials | 84:04.04 - Antibacterials; 8:12.02 - Aminoglycosides; 52:04.04 - Antibacterials |
| Gentak; Gentasol; Ocu-Mycin; Pred-G Liquifilm; Pred-G S.O.P. | Gentamicin Sulfate (EENT) | 10/29/2024 | 52:04.04 - Antibacterials | 52:04.04 - Antibacterials; 8:12.02 - Aminoglycosides; 84:04.04 - Antibacterials |
| Zirgan | Ganciclovir | 10/29/2024 | 52:04.20 - Antivirals | 52:04.20 - Antivirals; 8:18.32 - Nucleosides and Nucleotides |
| Fosinopril | 10/29/2024 | 24:32.04 - Angiotensin-Converting Enzyme Inhibitors; 24:08.92 - Vasodilating Agents, Miscellaneous | 24:32.04 - Angiotensin-Converting Enzyme Inhibitors | |
| Advair Diskus; Advair HFA; Flovent Diskus; Arnuity Ellipta; Flovent HFA; Trelegy Ellipta; Wixela Inhub | Fluticasone | 10/29/2024 | 68:04 - Adrenals | 68:04 - Adrenals; 48:10.08 - Corticosteroids; 52:08.08 - Corticosteroids |
| Flurbiprofen | 10/29/2024 | 28:08.04.04 - Reversible COX-1/COX-2 Inhibitors | 28:08.04.04 - Reversible COX-1/COX-2 Inhibitors; 52:08.20 - Nonsteroidal Anti-inflammatory Agents | |
| Beqvez | Fidanacogene elaparvovec | 10/29/2024 | 26:12 - Gene Therapy | 26:12 - Gene Therapy; 20:28.16 - Hemostatics |
| Plendil | Felodipine | 10/29/2024 | 24:28.08 - Dihydropyridines; 24:08.92 - Vasodilating Agents, Miscellaneous | 24:28.08 - Dihydropyridines |
| Afinitor; Afinitor Disperz; Zortress | Everolimus | 10/29/2024 | 10:00 - Antineoplastic Agents | 10:00 - Antineoplastic Agents; 90:00 - Immunomodulatory Agents |
| Vaseretic; Vasotec | Enalapril | 10/29/2024 | 24:32.04 - Angiotensin-Converting Enzyme Inhibitors; 24:08.44.04 - Angiotensin-Converting Enzyme Inhibitors | 24:32.04 - Angiotensin-Converting Enzyme Inhibitors |
| Trikafta | Elexacaftor, Tezacaftor, and Ivacaftor | 10/29/2024 | 48:14.04 - Cystic Fibrosis Transmembrane Conductance Regulator Correctors | 48:14.04 - Cystic Fibrosis Transmembrane Conductance Regulator Correctors; 48:14.12 - Cystic Fibrosis Transmembrane Conductance Regulator Potentiators |
| SINEquan; SINEquan Oral Concentrate | Doxepin | 10/29/2024 | 28:16.04.28 - Tricyclics and Other Norepinephrine-reuptake Inhibitors | 28:16.04.28 - Tricyclics and Other Norepinephrine-reuptake Inhibitors; 84:08 - Antipruritics and Local Anesthetics |
| Prudoxin; Zonalon | Doxepin | 10/29/2024 | 84:08 - Antipruritics and Local Anesthetics | 84:08 - Antipruritics and Local Anesthetics; 28:16.04.28 - Tricyclics and Other Norepinephrine-reuptake Inhibitors |
| Aggrenox; Persantine | Dipyridamole | 10/29/2024 | 36:18 - Cardiac Function; 20:12.18 - Platelet-aggregation Inhibitors | 36:18 - Cardiac Function |
| Cardizem | dilTIAZem | 10/29/2024 | 24:04.04.24 - Class IV Antiarrhythmics; 24:28 - Calcium-Channel Blocking Agents | 24:04.04.24 - Class IV Antiarrhythmics |
| Solaraze | Diclofenac | 10/29/2024 | 84:06.20 - Nonsteroidal Anti-inflammatory Agents | 84:06.20 - Nonsteroidal Anti-inflammatory Agents; 28:08.04.04 - Reversible COX-1/COX-2 Inhibitors |
| Decadron; DexaJect; Dexasone; Dexium; Dextenza | Dexamethasone | 10/29/2024 | 68:04 - Adrenals | 68:04 - Adrenals; 52:08.08 - Corticosteroids |
| Daxxify | DaxibotulinumtoxinA-lanm | 10/29/2024 | 12:20.20.24 - Botulinum toxins; 12:20.92 - Skeletal Muscle Relaxants, Miscellaneous | 12:20.20.24 - Botulinum toxins |
| Symtuza | Darunavir, Cobicistat, Emtricitabine, Tenofovir Alafenamide | 10/29/2024 | 8:18.08.08 - HIV Protease Inhibitors | 8:18.08.08 - HIV Protease Inhibitors; 8:18.08.20 - HIV Nucleoside and Nucleotide Reverse Transcriptase Inhibitors |
| Dapsone Tablets | Dapsone (Systemic) | 10/29/2024 | 8:16.08 - Antileprosy Agents; 84:04.04 - Antibacterials | 8:16.08 - Antileprosy Agents; 84:04.04 - Antibacterials; 8:30.92 - Antiprotozoals, Miscellaneous; 84:92 - Skin and Mucous Membrane Agents |
| Aczone | Dapsone (Topical) | 10/29/2024 | 84:04.04 - Antibacterials | 84:04.04 - Antibacterials; 8:16.08 - Antileprosy Agents; 8:30.92 - Antiprotozoals, Miscellaneous; 84:92 - Skin and Mucous Membrane Agents |
| Jesduvroq | Daprodustat | 10/29/2024 | 20:16 - Hematopoietic Agents | 20:16 - Hematopoietic Agents; 20:04 - Antianemia Drugs |
| Crolom; Nasalcrom | Cromolyn | 10/29/2024 | 52:02 - Antiallergic Agents; 52:92 - EENT Drugs, Miscellaneous | 52:02 - Antiallergic Agents; 52:92 - EENT Drugs, Miscellaneous; 48:10.32 - Mast-cell Stabilizers |
| Prevpac; Biaxin Filmtab; Biaxin Granules | Clarithromycin | 10/29/2024 | 8:12.12.08 - Other Macrolides; 8:16.04 - Antituberculosis Agents; 56:28 - Antiulcer Agents and Acid Suppressants | 8:12.12.08 - Other Macrolides; 8:16.04 - Antituberculosis Agents; 56:28 - Antiulcer Agents and Acid Suppressants; 56:28.18 - Potassium-competitive Acid Blockers |
| Leustatin | Cladribine | 10/29/2024 | 10:00 - Antineoplastic Agents | 10:00 - Antineoplastic Agents; 90:04.20 - Antimetabolites |
| Alvesco | Ciclesonide | 10/29/2024 | 68:04 - Adrenals; 52:08.08 - Corticosteroids | 68:04 - Adrenals; 52:08.08 - Corticosteroids; 68:04 - Adrenals; 52:08.08 - Corticosteroids; 48:10.08 - Corticosteroids |
| Iheezo | Chloroprocaine Hydrochloride (EENT) | 10/29/2024 | 52:16 - Local Anesthetics | 52:16 - Local Anesthetics; 72:00 - Local Anesthetics |
| Paroex; Peridex; PerioChip; PerioGard; PerioGard Alcohol Free | Chlorhexidine (EENT) | 10/29/2024 | 52:04.24 - Astringents; 84:04.16 - Astringents, Anti-infective | 52:04.24 - Astringents; 84:04.16 - Astringents, Anti-infective; 8:30.04 - Amebicides |
| Captopril | 10/29/2024 | 24:32.04 - Angiotensin-Converting Enzyme Inhibitors; 24:08.92 - Vasodilating Agents, Miscellaneous | 24:32.04 - Angiotensin-Converting Enzyme Inhibitors | |
| Tecartus | Brexucabtagene Autoleucel | 10/29/2024 | 26:12 - Gene Therapy | 26:12 - Gene Therapy; 10:00 - Antineoplastic Agents |
| Biktarvy | Bictegravir, Emtracitabine, Tenofovir Alafenamide | 10/29/2024 | 8:18.08.12 - HIV Integrase Inhibitors | 8:18.08.12 - HIV Integrase Inhibitors; 8:18.08.20 - HIV Nucleoside and Nucleotide Reverse Transcriptase Inhibitors |
| Betoptic S | Betaxolol (EENT) | 10/29/2024 | 52:40.08 - beta-Adrenergic Blocking Agents | 52:40.08 - beta-Adrenergic Blocking Agents; 12:16.08.08 - Selective beta-Adrenergic Blocking Agents; 24:04.04.16 - Class II Antiarrhythmics; 24:20 - beta-Adrenergic Blocking Agents |
| Cogentin | Benztropine | 10/29/2024 | 28:36.08 - Anticholinergic Agents | 28:36.08 - Anticholinergic Agents; 12:08.04 - Antiparkinsonian Agents |
| Android; Methitest; Testred | methylTESTOSTERone | 09/24/2024 | 68:08 - Androgens | 68:08 - Androgens; 68:18.04 - Antigonadotropins |
| Orgovyx | Relugolix | 09/24/2024 | 68:18.04 - Antigonadotropins | 68:18.04 - Antigonadotropins; 10:00 - Antineoplastic Agents |
| Compazine; Compro; Prochlorperazine Suppositories | Prochlorperazine (Antiemetic) | 09/24/2024 | 56:22.08 - Antihistamines | 56:22.08 - Antihistamines; 28:16.08.24 - Phenothiazines |
| Orapred; Pediapred; Prelone Syrup | prednisoLONE | 09/24/2024 | 68:04 - Adrenals | 68:04 - Adrenals; 52:08.08 - Corticosteroids |
| Pred-G; Pred Mild; Pred Forte; Inflamase Mild; AK-Pred; Blephamide; Econopred Plus | prednisoLONE (EENT) | 09/24/2024 | 52:08.08 - Corticosteroids | 52:08.08 - Corticosteroids; 68:04 - Adrenals |
| Cortisporin Otic Solution; Polytrim; Casporyn; Maxitrol | Polymyxin B | 09/24/2024 | 52:04.04 - Antibacterials | 52:04.04 - Antibacterials; 8:12.28.28 - Polymyxins; 84:04.04 - Antibacterials |
| Isopto Carpine; Pilopine HS | Pilocarpine | 09/24/2024 | 52:40.20 - Miotics | 52:40.20 - Miotics; 12:04 - Parasympathomimetic (Cholinergic) Agents |
| AK-Dilate; Ocu-Phrin; Neo-Synephrine | Phenylephrine (Mydriatics) | 09/24/2024 | 52:24 - Mydriatics | 52:24 - Mydriatics; 12:12.04 - alpha-Adrenergic Agonists; 52:32 - Vasoconstrictors |
| Murocoll; Cyclomydril; Dristan; Neo-Synephrine; Mydfrin | Phenylephrine (Vasoconstrictor) | 09/24/2024 | 52:32 - Vasoconstrictors | 52:32 - Vasoconstrictors; 12:12.04 - alpha-Adrenergic Agonists; 52:24 - Mydriatics |
| Luminal Sodium | PHENobarbital (Sedative) | 09/24/2024 | 28:24.04 - Barbiturates | 28:24.04 - Barbiturates; 28:12.04 - Barbiturates |
| Luminal Sodium; PHENobarbital Sodium Injection | PHENobarbital (Anticonvulsant) | 09/24/2024 | 28:12.04 - Barbiturates | 28:12.04 - Barbiturates; 28:24.04 - Barbiturates |
| Sylatron | Peginterferon Alfa | 09/24/2024 | 10:00 - Antineoplastic Agents; 8:18.20 - Interferons; 92:20 - Immunomodulatory Agents | 10:00 - Antineoplastic Agents; 8:18.20 - Interferons; 92:20 - Immunomodulatory Agents; 90:04.12 - Interferons |
| Syfovre | Pegcetacoplan | 09/24/2024 | 52:44 - Macular Degeneration Agents | 52:44 - Macular Degeneration Agents; 90:20 - Complement Inhibitor Agents |
| Upneeq; Visine L.R. Eye Drops; Zicam Intense Sinus Relief Nasal Gel; Afrin No Drip Original 12 Hour Pump Mist | Oxymetazoline Hydrochloride (EENT) | 09/24/2024 | 52:32 - Vasoconstrictors | 52:32 - Vasoconstrictors; 84:06.24 - Adrenergic Agonists |
| Oxandrolone | 09/24/2024 | 68:08 - Androgens | 68:08 - Androgens; 68:18.04 - Antigonadotropins | |
| Paregoric | Opium Preparations | 09/24/2024 | 56:08 - Antidiarrhea Agents | 56:08 - Antidiarrhea Agents; 28:08.08 - Opioid Agonists |
| Ocuflox | Ofloxacin | 09/24/2024 | 52:04.04 - Antibacterials | 52:04.04 - Antibacterials; 8:12.18 - Quinolones |
| Axid; Axid AR Acid Reducer; Axid Pulvules | Nizatidine | 09/24/2024 | 56:28.12 - Histamine H2-Antagonists | 56:28.12 - Histamine H2-Antagonists; 4:92 - Other Antihistamines |
| NitroMist; Nitrolingual; Nitro-Time; GoNitro; Nitrostat; Nitro-Dur; Minitran | Nitroglycerin (systemic) | 09/24/2024 | 24:08.08 - Nitrates and Nitrites; 84:92 - Skin and Mucous Membrane Agents, Miscellaneous | 24:08.08 - Nitrates and Nitrites; 84:92 - Skin and Mucous Membrane Agents, Miscellaneous; 84:24.12 - Basic Ointments and Protectants |
| Neosporin Ophthalmic Solution; Maxitrol | Neomycin (EENT) | 09/24/2024 | 52:04.04 - Antibacterials | 52:04.04 - Antibacterials; 8:12.02 - Aminoglycosides; 84:04.04 - Antibacterials |
| Asmanex HFA; Asmanex Twisthaler; Dulera | Mometasone Furoate (Oral Inhalation) | 09/24/2024 | 68:04 - Adrenals | 68:04 - Adrenals; 48:10.08 - Corticosteroids; 52:08.08 - Corticosteroids; 84:06.08 - Corticosteroids |
| Flagyl | metroNIDAZOLE | 09/24/2024 | 8:30.16.92 - Nitroimidazole Derivatives, Miscellaneous; 8:30.04 - Amebicides; 56:28 - Antiulcer Agents and Acid Suppressants; 84:04.04 - Antibacterials; 84:92 - Skin and Mucous Membrane Agents, Miscellaneous | 8:30.16.92 - Nitroimidazole Derivatives, Miscellaneous; 8:30.04 - Amebicides; 56:28 - Antiulcer Agents and Acid Suppressants; 84:04.04 - Antibacterials |
| MetroCream; MetroGel; MetroGel-Vaginal; MetroLotion; Noritate; Vandazole | metroNIDAZOLE (Topical) | 09/24/2024 | 84:04.04 - Antibacterials | 84:04.04 - Antibacterials; 8:30.16.92 - Nitroimidazole Derivatives, Miscellaneous; 8:30.04 - Amebicides; 56:28 - Antiulcer Agents and Acid Suppressants |
| Antivert; Bonine; Dramamine Less Drowsy; Meni-D | Meclizine | 09/24/2024 | 56:22.08 - Antihistamines | 56:22.08 - Antihistamines; 4:04 - First Generation Antihistamines |
| Alomide | Lodoxamide | 09/24/2024 | 52:02 - Antiallergic Agents; 4:08 - Second Generation Antihistamines | 52:02 - Antiallergic Agents; 4:08 - Second Generation Antihistamines; 48:10.32 - Mast-cell Stabilizers |
| Saxenda; Victoza; Xultophy | Liraglutide | 09/24/2024 | 68:20.06 - Incretin Mimetics | 68:20.06 - Incretin Mimetics; 28:20.08.92 - Anorexigenic Agents, Miscellaneous |
| Intron A | Interferon Alfa (Antineoplastic) | 09/24/2024 | 10:00 - Antineoplastic Agents; 8:18.20 - Interferons | 10:00 - Antineoplastic Agents; 8:18.20 - Interferons; 90:04.12 - Interferons |
| Solu-CORTEF; Cortef; A-hydroCort | Hydrocortisone | 09/24/2024 | 68:04 - Adrenals | 68:04 - Adrenals; 52:08.08 - Corticosteroids; 84:06.08 - Corticosteroids |
| Acetasol HC Otic Solution; Antibiotic Otic Solution; Antibiotic Otic Suspension; Ocu-Cort; VoSol HC Otic Solution | hydrocortisone (EENT) | 09/24/2024 | 52:08.08 - Corticosteroids | 52:08.08 - Corticosteroids; 68:04 - Adrenals; 84:06.08 - Corticosteroids |
| Ala-Cort®, Anucort-HC®, Anusert-HC®, Anusol-HC®, Cetacort®, Cortizone®, Dermacort®, Lanacort®, Proctocort®, Sarnol-HC | hydrocortisone (Topical) | 09/24/2024 | 84:06.08 - Corticosteroids | 84:06.08 - Corticosteroids; 52:08.08 - Corticosteroids; 68:04 - Adrenals |
| Flonase Nasal Spray | Fluticasone | 09/24/2024 | 52:08.08 - Corticosteroids | 52:08.08 - Corticosteroids; 68:04 - Adrenals; 48:10.08 - Corticosteroids |
| Gelato Home-care (keystone); Gel-Kam, Just for Kids; OMNI Gel; Fluoridex; PerioMed; Stance | Fluorides | 09/24/2024 | 34:04 - Nutritional supplement | 34:04 - Nutritional supplement; 92:28 - Cariostatic Agents |
| Synalar; Lidex | Fluocinolone | 09/24/2024 | 84:06.08 - Corticosteroids | 84:06.08 - Corticosteroids; 52:08.08 - Corticosteroids |
| Pepcid | Famotidine | 09/24/2024 | 56:28.12 - Histamine H2-Antagonists | 56:28.12 - Histamine H2-Antagonists; 4:92 - Other Antihistamines |
| Necon; Norinyl; Ortho-Novum; NuvaRing; Ortho Evra; Tri-Levlen 21; Ovral | Estrogen-Progestin Combinations | 09/24/2024 | 68:12 - Contraceptives | 68:12 - Contraceptives; 68:32 - Progestins; 68:16.04 - Estrogens; 68:18.04 - Antigonadotropins |
| Activella; Alora; Angeliq; Climara; Climara Pro; Elestrin; Vivelle; Vagifem | Estradiol | 09/24/2024 | 68:16.04 - Estrogens | 68:16.04 - Estrogens; 92:24 - Bone Resorption Inhibitors |
| Benzamycin; Erythromycin and Benzoyl Peroxide Gel | Erythromycin (Topical) | 09/24/2024 | 84:04.04 - Antibacterials | 84:04.04 - Antibacterials; 52:04.04 - Antibacterials; 8:12.12.04 - Erythromycins |
| DDAVP; Minirin; Stimate Nasal Spray | Desmopressin | 09/24/2024 | 68:28 - Pituitary | 68:28 - Pituitary; 20:28.16 - Hemostatics |
| Danazol | 09/24/2024 | 68:08 - Androgens | 68:08 - Androgens; 68:18.04 - Antigonadotropins | |
| Gengraf; Neoral; SandIMMUNE | cycloSPORINE | 09/24/2024 | 90:28.28.92 - Calcineurin Inhibitors, Miscellaneous | 90:28.28.92 - Calcineurin Inhibitors, Miscellaneous; 52:08 - Anti-inflammatory Agents |
| BenzaClin; Duac | Clindamycin | 09/24/2024 | 84:04.04 - Antibacterials | 84:04.04 - Antibacterials; 8:12.28.20 - Lincomycins |
| Tagamet | Cimetidine | 09/24/2024 | 56:28.12 - Histamine H2-Antagonists | 56:28.12 - Histamine H2-Antagonists; 4:92 - Other Antihistamines |
| Fortical®, Miacalcin® | Calcitonin | 09/24/2024 | 68:24.04 - Antiparathyroid Agents | 68:24.04 - Antiparathyroid Agents; 92:24 - Bone Resorption Inhibitors |
| Zynrelef | Bupivacaine and Meloxicam | 09/24/2024 | 72:00 - Local Anesthetics; 28:08.04.92 - Nonsteroidal Anti-inflammatory Agents, Miscellaneous | 72:00 - Local Anesthetics; 28:08.04.04 - Reversible COX-1/COX-2 Inhibitors |
| Celestone Soluspan | Betamethasone | 09/24/2024 | 68:04 - Adrenals | 68:04 - Adrenals; 84:06.08 - Corticosteroids |
| Alphatrex®, Betatrex®, Beta-Val®, Diprolene®, Luxiq®, Maxivate® | Betamethasone (Topical) | 09/24/2024 | 84:06.08 - Corticosteroids | 84:06.08 - Corticosteroids; 68:04 - Adrenals |
| Solarcaine; Rhulicream; Outgro; Ivarest | Benzocaine (Topical) | 09/24/2024 | 84:08 - Antipruritics and Local Anesthetics | 84:08 - Antipruritics and Local Anesthetics; 52:16 - Local Anesthetics |
| Neosporin | Bacitracin (Topical) | 09/24/2024 | 84:04.04 - Antibacterials | 84:04.04 - Antibacterials; 52:04.04 - Antibacterials |
| Scenesse | Afamelanotide | 09/24/2024 | 68:48 - Melanocortin Receptor Agonists | 68:48 - Melanocortin Receptor Agonists; 92:56 - Protective Agents; 84:80 - Sunscreen Agents |
| Zovirax | Acyclovir (Topical) | 09/24/2024 | 84:04.06 - Antivirals | 84:04.06 - Antivirals; 8:18.32 - Nucleosides and Nucleotides |
| Chantix | Varenicline | 08/28/2024 | 12:02 - Smoking Cessation Agents | 12:02 - Smoking Cessation Agents; 52:92 - EENT Drugs, Miscellaneous |
| Tezspire | Tezepelumab-ekko | 08/28/2024 | 48:10.20 - Interleukin Antagonists | 48:10.20 - Interleukin Antagonists; 8:18.24 - Monoclonal Antibodies |
| Advair Diskus; Advair HFA; AirDuo RespiClick | Salmeterol | 08/28/2024 | 12:12.08.12 - Selective beta-2-Adrenergic Agonists | 12:12.08.12 - Selective beta-2-Adrenergic Agonists; 48:12.04.12 - Selective beta-2-Adrenergic Agonists |
| Compazine; Compro | Prochlorperazine | 08/28/2024 | 28:16.08.24 - Phenothiazines | 28:16.08.24 - Phenothiazines; 56:22.08 - Antihistamines |
| Dilantin; Phenytek | Phenytoin | 08/28/2024 | 28:12.12 - Hydantoins | 28:12.12 - Hydantoins; 24:04.04.08 - Class Ib Antiarrhythmics |
| Nayzilam; Seizalam | Midazolam | 08/28/2024 | 28:24.08 - Benzodiazepines | 28:24.08 - Benzodiazepines; 28:12.08 - Benzodiazepines |
| Mircera | Methoxy Polyethylene Glycol-Epoetin Beta | 08/28/2024 | 20:16 - Hematopoietic Agents | 20:16 - Hematopoietic Agents; 20:04 - Antianemia Drugs |
| Orkambi | Lumacaftor and Ivacaftor | 08/28/2024 | 48:14.04 - Cystic Fibrosis Transmembrane Conductance Regulator Correctors | 48:14.04 - Cystic Fibrosis Transmembrane Conductance Regulator Correctors; 48:14.12 - Cystic Fibrosis Transmembrane Conductance Regulator Potentiators |
| Alferon N; Intron A | Interferon Alfa | 08/28/2024 | 8:18.20 - Interferons | 8:18.20 - Interferons; 10:00 - Antineoplastic Agents; 90:04.12 - Interferons |
| Anx; Atarax; Vistaril | hydrOXYzine | 08/28/2024 | 28:24.92 - Anxiolytics, Sedatives, and Hypnotics; Miscellaneous; 4:92 - Other Antihistamines; 4:04 - First Generation Antihistamines | 28:24.92 - Anxiolytics, Sedatives, and Hypnotics; Miscellaneous; 4:04 - First Generation Antihistamines |
| Ocufen | Flurbiprofen Sodium (EENT) | 08/28/2024 | 52:08.20 - Nonsteroidal Anti-inflammatory Agents | 52:08.20 - Nonsteroidal Anti-inflammatory Agents; 28:08.04.04 - Reversible COX-1/COX-2 Inhibitors |
| Retisert; Yutiq | Fluocinolone | 08/28/2024 | 52:08.08 - Corticosteroids | 52:08.08 - Corticosteroids; 84:06.08 - Corticosteroids |
| Nasalide; Nasarel | Flunisolide | 08/28/2024 | 52:08.08 - Corticosteroids | 52:08.08 - Corticosteroids; 48:10.08 - Corticosteroids; 68:04 - Adrenals |
| Romycin | Erythromycin | 08/28/2024 | 52:04.04 - Antibacterials | 52:04.04 - Antibacterials; 8:12.12.04 - Erythromycins; 84:04.04 - Antibacterials |
| Inspra | Eplerenone | 08/28/2024 | 24:32.20.08 - Steroidal Mineralocorticoid Receptor Antagonists; 24:36.16 - Potassium-sparing Diuretics; 40:28.16 - Potassium-sparing Diuretics; 24:08.44.20 - Mineralocorticoid (Aldosterone) Receptor Antagonists | 24:32.20.08 - Steroidal Mineralocorticoid Receptor Antagonists; 24:36.16 - Potassium-sparing Diuretics; 40:28.16 - Potassium-sparing Diuretics |
| Epinal | EPINEPHrine (Mydriatic) | 08/28/2024 | 52:24 - Mydriatics | 52:24 - Mydriatics; 52:40.92 - Antiglaucoma Agents, Miscellaneous; 12:12.12 - alpha- and beta-Adrenergic Agonists; 48:12.04.16 - alpha- and beta-Adrenergic Agonists; 52:32 - Vasoconstrictors |
| Adrenalin | EPINEPHrine (Vasoconstrictor) | 08/28/2024 | 52:32 - Vasoconstrictors | 52:32 - Vasoconstrictors; 12:12.12 - alpha- and beta-Adrenergic Agonists; 48:12.04.16 - alpha- and beta-Adrenergic Agonists; 52:24 - Mydriatics; 52:40.92 - Antiglaucoma Agents, Miscellaneous |
| S2 | EPINEPHrine | 08/28/2024 | 12:12.12 - alpha- and beta-Adrenergic Agonists; 48:12.04.16 - alpha- and beta-Adrenergic Agonists | 12:12.12 - alpha- and beta-Adrenergic Agonists; 48:12.04.16 - alpha- and beta-Adrenergic Agonists; 52:24 - Mydriatics; 52:32 - Vasoconstrictors; 52:40.92 - Antiglaucoma Agents, Miscellaneous |
| Elestat | Epinastine | 08/28/2024 | 52:02 - Antiallergic Agents | 52:02 - Antiallergic Agents; 4:08 - Second Generation Antihistamines |
| Atridox | Doxycycline | 08/28/2024 | 52:04.04 - Antibacterials | 52:04.04 - Antibacterials; 8:12.24 - Tetracyclines; 8:30.08 - Antimalarials; 84:04.04 - Antibacterials |
| Zerviate | Cetirizine | 08/28/2024 | 52:02 - Antiallergic Agents | 52:02 - Antiallergic Agents; 4:08 - Second Generation Antihistamines; 48:04.08 - Second Generation Antihistamines |
| Wellbutrin; Zyban | buPROPion | 08/28/2024 | 28:16.04.92 - Antidepressants, Miscellaneous | 28:16.04.92 - Antidepressants, Miscellaneous; 12:02 - Smoking Cessation Agents |
| Bepreve | Bepotastine | 08/28/2024 | 52:02 - Antiallergic Agents | 52:02 - Antiallergic Agents; 4:92 - Other Antihistamines |
| Beconase AQ Nasal Spray | Beclomethasone | 08/28/2024 | 52:08.08 - Corticosteroids; 48:10.08 - Corticosteroids | 52:08.08 - Corticosteroids; 48:10.08 - Corticosteroids; 68:04 - Adrenals |
| Neosporin Ophthalmic Ointment | Bacitracin | 08/28/2024 | 52:04.04 - Antibacterials | 52:04.04 - Antibacterials; 84:04.04 - Antibacterials |
| Astelin Nasal Spray; Optivar | Azelastine | 08/28/2024 | 52:02 - Antiallergic Agents; 48:04.08 - Second Generation Antihistamines | 52:02 - Antiallergic Agents; 4:08 - Second Generation Antihistamines |
| Atropine Care 1%; Isopto Atropine | Atropine | 08/28/2024 | 52:24 - Mydriatics | 52:24 - Mydriatics; 12:08.08 - Antimuscarinics/Antispasmodics; 91:00 - Antidote Therapeutics; 48:12.08 - Anticholinergic Agents |
| Aggrenox; Alka Seltzer Morning Relief; Alka-Seltzer Effervescent Pain Reliever and Antacid; Alka-Seltzer Extra Strength Effervescent Pain Reliever and Antacid; Alka-Seltzer Lemon-Lime Effervescent Pain Reliever and Antacid; Anacin; Ascriptin Arthritis Pai | Aspirin | 08/28/2024 | 28:08.04.24 - Salicylates; 20:12.20 - Thrombolytic Agents; 20:12.18 - Platelet-aggregation Inhibitors | 28:08.04.24 - Salicylates; 20:12.18 - Platelet-aggregation Inhibitors |
| Gocovri; Osmolex ER | Amantadine | 08/28/2024 | 28:36.04 - Adamantanes | 28:36.04 - Adamantanes; 8:18.04 - Adamantanes; 12:08.04 - Antiparkinsonian Agents |
| Lastacaft | Alcaftadine | 08/28/2024 | 52:02 - Antiallergic Agents | 52:02 - Antiallergic Agents; 4:08 - Second Generation Antihistamines |
| Diamox | acetaZOLAMIDE | 08/28/2024 | 52:40.12 - Carbonic Anhydrase Inhibitors | 52:40.12 - Carbonic Anhydrase Inhibitors; 24:36.04 - Carbonic Anhydrase Inhibitors; 28:12.92 - Anticonvulsants, Miscellaneous; 40:28.04 - Carbonic Anhydrase Inhibitors |
| Clear Eyes ACR; Visine A.C. | Zinc Sulfate | 08/28/2024 | 52:04.92 - Anti-infectives, Miscellaneous | 40:12 - Replacement Preparations |
| Gelato Home-care (keystone); Gel-Kam, Just for Kids; OMNI Gel; Fluoridex; PerioMed; Stance | Fluorides | 08/28/2024 | 34:00 - Dental Agents | 34:04 - Nutritional supplement |
| Romazicon | Flumazenil | 08/28/2024 | 28:92 - Central Nervous System Agents, Miscellaneous | 91:32.04 - GABA-mediated Benzodiazepine Antidotes |
| Genosyl; INOmax | Nitric Oxide | 08/28/2024 | 24:08.08 - Nitrates and Nitrites | 48:48.92 - Vasodilating Agents, Miscellaneous; 24:08.08 - Nitrates and Nitrites |
| Urea | 08/07/2024 | 40:28.12 - Osmotic Diuretics; 24:08.24.12 - Osmotic Diuretics | 40:28.12 - Osmotic Diuretics; 24:08.24.12 - Osmotic Diuretics; 24:36.12 - Osmotic Diuretics | |
| Cialis | Tadalafil | 08/07/2024 | 24:12.12 - Phosphodiesterase Type 5 Inhibitors | 24:08.12 - Phosphodiesterase Type 5 Inhibitors; 48:48.24 - Phosphodiesterase Type 5 Inhibitors |
| AlyQ; Adcirca | Tadalafil | 08/07/2024 | 48:48.24 - Phosphodiesterase Type 5 Inhibitors | 48:48.24 - Phosphodiesterase Type 5 Inhibitors; 24:08.12 - Phosphodiesterase Type 5 Inhibitors |
| Ampyra | Dalfampridine | 07/29/2024 | 92:92 - Other Miscellaneous Therapeutic Agents | 92:56 - Protective Agents |
| Daliresp | Roflumilast | 07/29/2024 | 48:32 - Phosphodiesterase Type 4 Inhibitors | 48:32 - Phosphodiesterase Type 4 Inhibitors; 84:06.12 - Phosphodiesterase-4 Inhibitors |
| Zoryve | Roflumilast | 07/29/2024 | 84:92 - Skin and Mucous Membrane Agents, Miscellaneous | 84:06.12 - Phosphodiesterase-4 Inhibitors; 48:32 - Phosphodiesterase Type 4 Inhibitors |
| Vesanoid | Tretinoin | 06/28/2024 | 10:00 - Antineoplastic Agents | 10:00 - Antineoplastic Agents; 84:16 - Cell Stimulants and Proliferants |
| Scopace; Transderm Scop | Scopolamine | 06/28/2024 | 12:08.08 - Antimuscarinics/Antispasmodics | 12:08.08 - Antimuscarinics/Antispasmodics; 56:24 - Lipotropic Agents; 56:22.92 - Antiemetics, Miscellaneous |
| Jakafi | Ruxolitinib | 06/28/2024 | 10:00 - Antineoplastic Agents | 10:00 - Antineoplastic Agents; 84:06.16 - Janus Kinase Inhibitors |
| Sylatron | Peginterferon Alfa | 06/28/2024 | 10:00 - Antineoplastic Agents | 10:00 - Antineoplastic Agents; 8:18.20 - Interferons; 92:20 - Immunomodulatory Agents |
| Remeron | Mirtazapine | 06/28/2024 | 28:16.04.92 - Antidepressants, Miscellaneous | 28:16.04.24 - Serotonin Modulators |
| Lidocaine | 06/28/2024 | 72:00 - Local Anesthetics | 72:00 - Local Anesthetics; 84:08 - Antipruritics and Local Anesthetics; 24:04.04.08 - Class Ib Antiarrhythmics | |
| Lidocaine | 06/28/2024 | 84:08 - Antipruritics and Local Anesthetics | 84:08 - Antipruritics and Local Anesthetics; 72:00 - Local Anesthetics; 24:04.04.08 - Class Ib Antiarrhythmics | |
| Revlimid | Lenalidomide | 06/28/2024 | 10:00 - Antineoplastic Agents | 10:00 - Antineoplastic Agents; 92:20 - Immunomodulatory Agents |
| Yodoxin | Iodoquinol | 06/28/2024 | 8:30.04 - Amebicides; 84:04.92 - Local Anti-infectives, Miscellaneous | 8:30.04 - Amebicides; 84:04.16 - Astringents, Anti-infective |
| Dificid | Fidaxomicin | 06/28/2024 | 8:12.12.92 - Other Macrolides | 8:12.12.08 - Other Macrolides |
| Prevpac; Biaxin Filmtab; Biaxin Granules | Clarithromycin | 06/28/2024 | 8:12.12.92 - Other Macrolides; 8:16.04 - Antituberculosis Agents; 56:28 - Antiulcer Agents and Acid Suppressants | 8:12.12.08 - Other Macrolides; 8:16.04 - Antituberculosis Agents; 56:28 - Antiulcer Agents and Acid Suppressants |
| Asparlas | Calaspargase pegol | 06/28/2024 | 10:00 - Antineoplastic Agents | 10:00 - Antineoplastic Agents; 44:00 - Enzymes |
| Zithromax; Zmax | Azithromycin | 06/28/2024 | 8:12.12.92 - Other Macrolides | 8:12.12.08 - Other Macrolides |
| Campath | Alemtuzumab | 06/28/2024 | 10:00 - Antineoplastic Agents; 92:20 - Immunomodulatory Agents | 10:00 - Antineoplastic Agents; 92:20 - Immunomodulatory Agents; 90:04.04 - Monoclonal Antibodies |
| Proleukin | Aldesleukin | 06/28/2024 | 10:00 - Antineoplastic Agents | 10:00 - Antineoplastic Agents; 92:20 - Immunomodulatory Agents |
| Rinvoq | Upadacitinib | 05/28/2024 | 92:36 - Disease-modifying Antirheumatic Drugs | 90:24.12.92 - Janus Kinase Inhibitors, Miscellaneous |
| Tremfya | Guselkumab | 05/28/2024 | 84:06.28 - Immunomodulatory Agents | 84:06.28 - Immunomodulatory Agents; 90:24 - Disease-modifying Antirheumatic Drugs |
| Avodart | Dutasteride | 05/28/2024 | 92:04 - 5-alpha-Reductase Inhibitors | |
| ReVia; Vivitrol | Naltrexone | 05/28/2024 | 28:10 - Opioid Antagonists | 28:10 - Opioid Antagonists; 12:02 - Smoking Cessation Agents |
| Recorlev | Levoketoconazole | 05/28/2024 | 92:92 - Other Miscellaneous Therapeutic Agents | 68:04 - Adrenals |
| Ridaura | Auranofin | 05/28/2024 | 60:00 - Gold Compounds; 92:36 - Disease-modifying Antirheumatic Drugs; 92:20 - Immunomodulatory Agents | 60:00 - Gold Compounds; 92:20 - Immunomodulatory Agents; 90:24 - Disease-modifying Antirheumatic Drugs |
| Alphagan P | Brimonidine | 05/28/2024 | 52:40.04 - alpha-Adrenergic Agonists | 52:40.04 - alpha-Adrenergic Agonists; 84:06.24 - Adrenergic Agonists |
| Omlonti | Omidenepag isopropyl | 05/28/2024 | 52:40.92 - Antiglaucoma Agents, Miscellaneous | 52:40.28 - Prostaglandin Analogs |
| Xiidra | Lifitegrast | 05/28/2024 | 52:08.92 - Anti-inflammatory Agents, Miscellaneous | 52:08 - Anti-inflammatory Agents |
| Cequa; Optimmune; Restasis | cycloSPORINE | 05/28/2024 | 52:08.92 - Anti-inflammatory Agents, Miscellaneous | 52:08 - Anti-inflammatory Agents; 90:28.28.92 - Calcineurin Inhibitors, Miscellaneous |
| Visudyne | Verteporfin | 05/28/2024 | 52:92 - EENT Drugs, Miscellaneous | 52:44 - Macular Degeneration Agents |
| Syfovre | Pegcetacoplan | 05/28/2024 | 52:92 - EENT Drugs, Miscellaneous | 52:44 - Macular Degeneration Agents |
| Jetrea | Ocriplasmin | 05/28/2024 | 52:92 - EENT Drugs, Miscellaneous | 52:44 - Macular Degeneration Agents |
| Cystaran | Cysteamine | 05/28/2024 | 52:92 - EENT Drugs, Miscellaneous | 52:44 - Macular Degeneration Agents |
| Iopidine | Apraclonidine | 05/28/2024 | 52:92 - EENT Drugs, Miscellaneous | 52:40.04 - alpha-Adrenergic Agonists |
| Tepezza | Teprotumumab | 05/28/2024 | 52:92 - EENT Drugs, Miscellaneous | 52:08 - Anti-inflammatory Agents |
| Miebo | Perfluorohexyloctane | 05/28/2024 | 52:92 - EENT Drugs, Miscellaneous | 52:08 - Anti-inflammatory Agents |
| Oxervate | Cenegermin | 05/28/2024 | 52:92 - EENT Drugs, Miscellaneous | 52:08 - Anti-inflammatory Agents |
| Paroex; Peridex; PerioChip; PerioGard; PerioGard Alcohol Free | Chlorhexidine | 05/28/2024 | 52:04.92 - Anti-infectives, Miscellaneous | 52:04.24 - Astringents; 84:04.16 - Astringents, Anti-infective |
| Auro Ear Wax Removal Aid; Cankaid Mouth Treatment; Debrox Drops; E.R.O. Ear Drops; Gly-Oxide; Mollifene Ear Wax Removing Formula; Murine Ear Drops; Orajel Perioseptic | Carbamide Peroxide | 05/28/2024 | 52:04.92 - Anti-infectives, Miscellaneous | 52:04.24 - Astringents |
| Ilaris | Canakinumab | 05/28/2024 | 92:92 - Other Miscellaneous Therapeutic Agents | 48:10.20 - Interleukin Antagonists; 8:18.24 - Monoclonal Antibodies |
| Hetlioz | Tasimelteon | 05/28/2024 | 28:24.92 - Anxiolytics, Sedatives, and Hypnotics; Miscellaneous | 28:24.48 - Melatonin Receptor Agonists |
| Rozerem | Ramelteon | 05/28/2024 | 28:24.92 - Anxiolytics, Sedatives, and Hypnotics; Miscellaneous | 28:24.48 - Melatonin Receptor Agonists |
| Zolpidem | 05/28/2024 | 28:24.92 - Anxiolytics, Sedatives, and Hypnotics; Miscellaneous | 28:24.44 - Non-benzodiazepine Hypnotics | |
| Sonata | Zaleplon | 05/28/2024 | 28:24.92 - Anxiolytics, Sedatives, and Hypnotics; Miscellaneous | 28:24.44 - Non-benzodiazepine Hypnotics |
| Lunesta | Eszopiclone | 05/28/2024 | 28:24.92 - Anxiolytics, Sedatives, and Hypnotics; Miscellaneous | 28:24.44 - Non-benzodiazepine Hypnotics |
| Equagesic | Meprobamate | 05/28/2024 | 28:24.92 - Anxiolytics, Sedatives, and Hypnotics; Miscellaneous | 28:24.12 - Non-benzodiazepine Anxiolytics |
| BuSpar | busPIRone | 05/28/2024 | 28:24.92 - Anxiolytics, Sedatives, and Hypnotics; Miscellaneous | 28:24.12 - Non-benzodiazepine Anxiolytics |
| Qalsody | Tofersen | 05/28/2024 | 28:92 - Central Nervous System Agents, Miscellaneous | 28:44 - Amyotrophic Lateral Sclerosis (ALS) Agents |
| Sodium phenylbutyrate/taurursodiol | 05/28/2024 | 28:92 - Central Nervous System Agents, Miscellaneous | 28:44 - Amyotrophic Lateral Sclerosis (ALS) Agents | |
| Exservan; Rilutek; Tiglutik | Riluzole | 05/28/2024 | 28:92 - Central Nervous System Agents, Miscellaneous | 28:44 - Amyotrophic Lateral Sclerosis (ALS) Agents |
| Radicava | Edaravone | 05/28/2024 | 28:92 - Central Nervous System Agents, Miscellaneous | 28:44 - Amyotrophic Lateral Sclerosis (ALS) Agents |
| Nourianz | Istradefylline | 05/28/2024 | 28:92 - Central Nervous System Agents, Miscellaneous | 28:36.24 - Adenosine A2A Receptor Antagonists |
| Xyrem; Xywav | Sodium Oxybate | 05/28/2024 | 28:92 - Central Nervous System Agents, Miscellaneous | 28:20.80 - Wakefulness-promoting Agents; 92:18 - Antisense Oligonucleotides |
| Qelbree | Viloxazine | 05/28/2024 | 28:92 - Central Nervous System Agents, Miscellaneous | 28:20.32 - Respiratory and CNS Stimulants |
| Strattera | Atomoxetine | 05/28/2024 | 28:92 - Central Nervous System Agents, Miscellaneous | 28:20.32 - Respiratory and CNS Stimulants |
| Qsymia | Phentermine and Topiramate | 05/28/2024 | 28:20.08.92 - Anorexigenic Agents, Miscellaneous | 28:20.08 - Anorexigenic Agents |
| Contrave | Naltrexone and Bupropion | 05/28/2024 | 28:20.08.92 - Anorexigenic Agents, Miscellaneous | 28:20.08 - Anorexigenic Agents |
| Orap | Pimozide | 05/28/2024 | 28:16.08.92 - Antipsychotics, Miscellaneous | 28:16.08.30 - Diphenylbutylperidines |
| Molindone | 05/28/2024 | 28:16.08.92 - Antipsychotics, Miscellaneous | 28:16.08.28 - Dihydroindolones | |
| Loxitane | Loxapine | 05/28/2024 | 28:16.08.92 - Antipsychotics, Miscellaneous | 28:16.08.26 - Dibenzoxapines |
| Spravato | Ketamine | 05/28/2024 | 28:16.04.92 - Antidepressants, Miscellaneous | 28:16.04.06 - NMDA Antagonists |
| Zulresso | Brexanolone | 05/28/2024 | 28:16.04.92 - Antidepressants, Miscellaneous | 28:16.04.04 - GABA Modulators |
| Sabril | Vigabatrin | 05/28/2024 | 28:12.92 - Anticonvulsants, Miscellaneous | 28:12.28 - GABA-mediated Anticonvulsants |
| Depacon; Depakene; Depakote; Stavzor | Valproate/Divalproex | 05/28/2024 | 28:12.92 - Anticonvulsants, Miscellaneous; 28:28 - Antimanic Agents; 28:32.92 - Antimigraine Agents, Miscellaneous | 28:12.28 - GABA-mediated Anticonvulsants; 28:28 - Antimanic Agents; 28:32.92 - Antimigraine Agents, Miscellaneous |
| Gabitril | tiaGABine | 05/28/2024 | 28:12.92 - Anticonvulsants, Miscellaneous | 28:12.28 - GABA-mediated Anticonvulsants |
| Diacomit | Stiripentol | 05/28/2024 | 28:12.92 - Anticonvulsants, Miscellaneous | 28:12.28 - GABA-mediated Anticonvulsants |
| Lyrica | Pregabalin | 05/28/2024 | 28:12.92 - Anticonvulsants, Miscellaneous; 28:40 - Fibromyalgia Agents | 28:12.28 - GABA-mediated Anticonvulsants; 28:40 - Fibromyalgia Agents |
| Ztalmy | Ganaxolone | 05/28/2024 | 28:12.92 - Anticonvulsants, Miscellaneous | 28:12.28 - GABA-mediated Anticonvulsants |
| Gralise; Horizant; Neurontin | Gabapentin | 05/28/2024 | 28:12.92 - Anticonvulsants, Miscellaneous; 28:08.92 - Analgesics and Antipyretics, Miscellaneous | 28:12.28 - GABA-mediated Anticonvulsants; 28:08.92 - Analgesics and Antipyretics, Miscellaneous |
| Zonegran | Zonisamide | 05/28/2024 | 28:12.92 - Anticonvulsants, Miscellaneous | 28:12.24 - Ion Channel Inhibition Agents |
| Banzel | Rufinamide | 05/28/2024 | 28:12.92 - Anticonvulsants, Miscellaneous | 28:12.24 - Ion Channel Inhibition Agents |
| Trileptal | OXcarbazepine | 05/28/2024 | 28:12.92 - Anticonvulsants, Miscellaneous | 28:12.24 - Ion Channel Inhibition Agents |
| Vimpat | Lacosamide | 05/28/2024 | 28:12.92 - Anticonvulsants, Miscellaneous | 28:12.24 - Ion Channel Inhibition Agents |
| Aptiom | Eslicarbazepine | 05/28/2024 | 28:12.92 - Anticonvulsants, Miscellaneous | 28:12.24 - Ion Channel Inhibition Agents |
| XCopri | Cenobamate | 05/28/2024 | 28:12.92 - Anticonvulsants, Miscellaneous | 28:12.24 - Ion Channel Inhibition Agents |
| Prialt | Ziconotide | 05/28/2024 | 28:08.92 - Analgesics and Antipyretics, Miscellaneous | 28:08.16 - Non-Opioid Analgesics |
| Acephen | Acetaminophen | 05/28/2024 | 28:08.92 - Analgesics and Antipyretics, Miscellaneous; 28:32.92 - Antimigraine Agents, Miscellaneous | 28:08.16 - Non-Opioid Analgesics; 28:32.92 - Antimigraine Agents, Miscellaneous |
| N/A | riTUXimab | 05/28/2024 | 10:00 - Antineoplastic Agents; 92:36 - Disease-modifying Antirheumatic Drugs | 10:00 - Antineoplastic Agents; 90:24 - Disease-modifying Antirheumatic Drugs |
| N/A | Methotrexate | 05/28/2024 | 10:00 - Antineoplastic Agents; 92:20 - Immunomodulatory Agents; 92:44 - Immunosuppressive Agents; 92:36 - Disease-modifying Antirheumatic Drugs | 10:00 - Antineoplastic Agents; 90:24 - Disease-modifying Antirheumatic Drugs |
| Purinethol | Mercaptopurine | 05/28/2024 | 10:00 - Antineoplastic Agents; 92:44 - Immunosuppressive Agents | 10:00 - Antineoplastic Agents; 90:00 - Immunomodulatory Agents |
| Cytoxan | Cyclophosphamide | 05/28/2024 | 10:00 - Antineoplastic Agents; 92:44 - Immunosuppressive Agents | 10:00 - Antineoplastic Agents; 90:00 - Immunomodulatory Agents |
| BC Powder | Salicylamide | 05/24/2024 | 28:08.92 - Analgesics and Antipyretics, Miscellaneous | 28:08.04.24 - Salicylates |
| Sulindac | 05/24/2024 | 28:08.04.92 - Other Nonsteroidal Anti-inflammatory Agents | 28:08.04.04 - Reversible COX-1/COX-2 Inhibitors | |
| Feldene | Piroxicam | 05/24/2024 | 28:08.04.92 - Other Nonsteroidal Anti-inflammatory Agents | 28:08.04.04 - Reversible COX-1/COX-2 Inhibitors |
| Daypro | Oxaprozin | 05/24/2024 | 28:08.04.92 - Other Nonsteroidal Anti-inflammatory Agents | 28:08.04.04 - Reversible COX-1/COX-2 Inhibitors |
| Aleve; Anaprox; EC-Naprosyn; Naprelan; Naprosyn; Treximet; Vimovo | Naproxen | 05/24/2024 | 28:08.04.92 - Other Nonsteroidal Anti-inflammatory Agents; 92:16 - Antigout Agents | 28:08.04.04 - Reversible COX-1/COX-2 Inhibitors; 92:16 - Antigout Agents |
| Nabumetone | 05/24/2024 | 28:08.04.92 - Other Nonsteroidal Anti-inflammatory Agents | 28:08.04.04 - Reversible COX-1/COX-2 Inhibitors | |
| Anjeso; Loxicom; Meloxidyl; Mobic; Ostilox; Qmiiz ODT | Meloxicam | 05/24/2024 | 28:08.04.92 - Other Nonsteroidal Anti-inflammatory Agents | 28:08.04.04 - Reversible COX-1/COX-2 Inhibitors |
| Ponstel | Mefenamic Acid | 05/24/2024 | 28:08.04.92 - Other Nonsteroidal Anti-inflammatory Agents | 28:08.04.04 - Reversible COX-1/COX-2 Inhibitors |
| Meclofenamate | 05/24/2024 | 28:08.04.92 - Other Nonsteroidal Anti-inflammatory Agents | 28:08.04.04 - Reversible COX-1/COX-2 Inhibitors | |
| Sprix | Ketorolac | 05/24/2024 | 28:08.04.92 - Other Nonsteroidal Anti-inflammatory Agents | 28:08.04.04 - Reversible COX-1/COX-2 Inhibitors; 52:08.20 - Nonsteroidal Anti-inflammatory Agents |
| Ketoprofen | 05/24/2024 | 28:08.04.92 - Other Nonsteroidal Anti-inflammatory Agents; 28:32.92 - Antimigraine Agents, Miscellaneous | 28:08.04.04 - Reversible COX-1/COX-2 Inhibitors | |
| Indocin | Indomethacin | 05/24/2024 | 28:08.04.92 - Other Nonsteroidal Anti-inflammatory Agents; 92:16 - Antigout Agents | 28:08.04.04 - Reversible COX-1/COX-2 Inhibitors; 92:16 - Antigout Agents |
| Ibuprofen | 05/24/2024 | 28:08.04.92 - Other Nonsteroidal Anti-inflammatory Agents | 28:08.04.04 - Reversible COX-1/COX-2 Inhibitors | |
| Flurbiprofen | 05/24/2024 | 28:08.04.92 - Other Nonsteroidal Anti-inflammatory Agents | 28:08.04.04 - Reversible COX-1/COX-2 Inhibitors | |
| Nalfon | Fenoprofen | 05/24/2024 | 28:08.04.92 - Other Nonsteroidal Anti-inflammatory Agents | 28:08.04.04 - Reversible COX-1/COX-2 Inhibitors |
| Etodolac | 05/24/2024 | 28:08.04.92 - Other Nonsteroidal Anti-inflammatory Agents | 28:08.04.04 - Reversible COX-1/COX-2 Inhibitors | |
| Diflunisal | 05/24/2024 | 28:08.04.92 - Other Nonsteroidal Anti-inflammatory Agents | 28:08.04.04 - Reversible COX-1/COX-2 Inhibitors | |
| Arthrotec; Cambia; Cataflam; Dyloject; Flector; Licart; Pennsaid; Voltaren; Zipsor; Zorvolex | Diclofenac | 05/24/2024 | 28:08.04.92 - Other Nonsteroidal Anti-inflammatory Agents; 28:32.92 - Antimigraine Agents, Miscellaneous | 28:08.04.04 - Reversible COX-1/COX-2 Inhibitors; 84:06.20 - Nonsteroidal Anti-inflammatory Agents |
| Diprivan Emulsion | Propofol | 05/24/2024 | 28:04.92 - General Anesthetics, Miscellaneous; 28:24.92 - Anxiolytics, Sedatives, and Hypnotics; Miscellaneous | 28:04.08 - Non-barbiturates; 28:24.92 - Anxiolytics, Sedatives, and Hypnotics; Miscellaneous |
| Ketalar | Ketamine | 05/24/2024 | 28:04.92 - General Anesthetics, Miscellaneous | 28:04.08 - Non-barbiturates |
| Amidate | Etomidate | 05/24/2024 | 28:04.92 - General Anesthetics, Miscellaneous | 28:04.08 - Non-barbiturates |
| Aldactazide; Aldactone | Spironolactone | 05/24/2024 | 24:32.20.08 - Steroidal Mineralocorticoid Receptor Antagonists; 24:08.44.20 - Mineralocorticoid (Aldosterone) Receptor Antagonists; 24:32.20.08 - Steroidal Mineralocorticoid Receptor Antagonists; 40:28.16 - Potassium-sparing Diuretics | 24:32.20.08 - Steroidal Mineralocorticoid Receptor Antagonists; 24:36.16 - Potassium-sparing Diuretics |
| Acetadote; Mucomyst | Acetylcysteine | 05/24/2024 | 92:12 - Antidotes; 48:24 - Mucolytic Agents | 91:04.04 - Acetaminophen antidote; 48:24 - Mucolytic Agents |
| AquaMEPHYTON; Mephyton | Phytonadione | 05/24/2024 | 88:24 - Vitamin K Activity; 92:12 - Antidotes | 88:24 - Vitamin K Activity; 91:00 - Antidote Therapeutics |
| Digibind; DigiFab | Digoxin Immune Fab | 05/24/2024 | 80:04 - Antitoxins and Immune Globulins; 92:12 - Antidotes | 80:04 - Antitoxins and Immune Globulins; 91:00 - Antidote Therapeutics |
| Anavip; CroFab | Crotalidae Polyvalent Immune Fab | 05/24/2024 | 80:04 - Antitoxins and Immune Globulins; 92:12 - Antidotes | 80:04 - Antitoxins and Immune Globulins; 91:00 - Antidote Therapeutics |
| Anavip | Crotalidae Immune F(ab')2 (Equine) | 05/24/2024 | 80:04 - Antitoxins and Immune Globulins | 80:04 - Antitoxins and Immune Globulins; 91:00 - Antidote Therapeutics |
| Anascorp | Centruroides Immune F(ab')2 | 05/24/2024 | 80:04 - Antitoxins and Immune Globulins; 92:12 - Antidotes | 80:04 - Antitoxins and Immune Globulins; 91:00 - Antidote Therapeutics |
| N/A | Antivenin (Micrurus fulvius) (Equine) | 05/24/2024 | 80:04 - Antitoxins and Immune Globulins; 92:12 - Antidotes | 80:04 - Antitoxins and Immune Globulins; 91:00 - Antidote Therapeutics |
| N/A | Antivenin (Latrodectus mactans) (Equine) | 05/24/2024 | 80:04 - Antitoxins and Immune Globulins; 92:12 - Antidotes | 80:04 - Antitoxins and Immune Globulins; 91:00 - Antidote Therapeutics |
| Iosat; Lugol's Solution; SSKI; ThyroSafe; ThyroShield | Potassium Iodide | 05/24/2024 | 68:36.08 - Antithyroid Agents; 92:12 - Antidotes; 48:16 - Expectorants; 8:14.92 - Antifungals, Miscellaneous | 68:36.08 - Antithyroid Agents; 48:16 - Expectorants; 8:14.92 - Antifungals, Miscellaneous; 91:00 - Antidote Therapeutics |
| Chemet | Succimer | 05/24/2024 | 64:00 - Heavy Metal Antagonists; 92:12 - Antidotes | 64:00 - Heavy Metal Antagonists; 91:00 - Antidote Therapeutics |
| Baqsimi; Gvoke | Glucagon | 05/24/2024 | 68:22.12 - Glycogenolytic Agents; 92:12 - Antidotes | 68:22.12 - Glycogenolytic Agents; 91:00 - Antidote Therapeutics |
| Cuprimine; Depen Titratable | penicillAMINE | 05/24/2024 | 64:00 - Heavy Metal Antagonists; 92:36 - Disease-modifying Antirheumatic Drugs | 64:00 - Heavy Metal Antagonists; 91:00 - Antidote Therapeutics |
| N/A | Edetate Calcium Disodium | 05/24/2024 | 64:00 - Heavy Metal Antagonists; 92:12 - Antidotes | 64:00 - Heavy Metal Antagonists; 91:00 - Antidote Therapeutics |
| BAL in Oil | Dimercaprol | 05/24/2024 | 64:00 - Heavy Metal Antagonists; 92:12 - Antidotes | 64:00 - Heavy Metal Antagonists; 91:00 - Antidote Therapeutics |
| Desferal | Deferoxamine | 05/24/2024 | 64:00 - Heavy Metal Antagonists; 92:12 - Antidotes | 64:00 - Heavy Metal Antagonists; 91:00 - Antidote Therapeutics |
| Alka-Mints; Calcet; Calci-Chew; Calci-Mix; Calphosan; Citracal; Titralac | Calcium Salts | 05/24/2024 | 40:12 - Replacement Preparations; ; 40:18.19 - Phosphate-reducing Agents; 92:12 - Antidotes | 40:12 - Replacement Preparations; ; 40:18.19 - Phosphate-reducing Agents; 91:00 - Antidote Therapeutics |
| Physostigmine Salicylate Injection | Physostigmine | 05/24/2024 | 12:04 - Parasympathomimetic (Cholinergic) Agents; 92:12 - Antidotes | 12:04 - Parasympathomimetic (Cholinergic) Agents; 91:00 - Antidote Therapeutics |
| Anaspaz; Cystospaz; Levbid; Levsin; NuLev; Symax DuoTab; Symax FasTab; Symax SL; Symax SR | Hyoscyamine | 05/24/2024 | 12:08.08 - Antimuscarinics/Antispasmodics | 12:08.08 - Antimuscarinics/Antispasmodics; 91:00 - Antidote Therapeutics |
| N/A | Amyl Nitrite | 05/21/2024 | 24:08.08 - Nitrates and Nitrites; 92:12 - Antidotes | 24:08.08 - Nitrates and Nitrites; 91:04.24 - Cyanide antidotes |
| N/A | Protamine | 05/21/2024 | 20:28.08 - Antiheparin Agents; 92:12 - Antidotes | 20:28.08 - Antiheparin Agents; 91:04 - Antidotes |
| Praxbind | idaruCIZUmab | 05/21/2024 | 20:28.92 - Antihemorrhagic Agents, Miscellaneous | 20:28.92 - Antihemorrhagic Agents, Miscellaneous; 91:04 - Antidotes |
| Andexxa | Factor Xa (recombinant), inactivated | 05/21/2024 | 20:28.16 - Hemostatics | 20:28.16 - Hemostatics; 91:04 - Antidotes |
| Bevespi; Cuvposa; Glyrx-PF; Lonhala, Robinul, Seebri, Utibron | Glycopyrrolate | 05/21/2024 | 12:08.08 - Antimuscarinics/Antispasmodics | 12:08.08 - Antimuscarinics/Antispasmodics; 84:12 - Astringents |
| Jakafi | Ruxolitinib | 05/21/2024 | 10:00 - Antineoplastic Agents | 10:00 - Antineoplastic Agents; 84:06.16 - Janus Kinase Inhibitors |
| Adrucil | Fluorouracil | 05/21/2024 | 10:00 - Antineoplastic Agents | 10:00 - Antineoplastic Agents; 84:18 - Antiproliferants |
| Vistogard; Xuriden | Uridine Triacetate | 04/29/2024 | 92:12 - Antidotes | 91:04.32 - Fluoropyrimidine antidote |
| Antizol | Fomepizole | 04/29/2024 | 92:12 - Antidotes | 91:04.08 - Methanol or ethylene glycol poisoning |
| Proscar | Finasteride | 04/29/2024 | 92:08 - 5-alpha-Reductase Inhibitors | 92:04 - 5-alpha-Reductase Inhibitors; 84:16 - Cell Stimulants and Proliferants |
| Veopoz | Pozelimab | 04/29/2024 | 92:32.08 - Complement Inhibitors | 92:32 - Complement Inhibitors |
| Ruconest | C1 Esterase Inhibitor (Recombinant) | 04/29/2024 | 92:32.08 - Complement Inhibitors | 92:32 - Complement Inhibitors |
| Berinert; Cinryze; Haegarda | C1 Esterase Inhibitor (Human) | 04/29/2024 | 92:32.08 - Complement Inhibitors | 92:32 - Complement Inhibitors |
| Orencia | Abatacept | 04/29/2024 | 92:36 - Disease-modifying Antirheumatic Drugs; 92:20 - Immunomodulatory Agents | 90:24.92 - Disease-modifying Antirheumatic Drugs, Miscellaneous; 92:20 - Immunomodulatory Agents |
| Cosela | Trilaciclib | 04/29/2024 | 92:56 - Protective Agents | 91:04.12 - Chemotherapy antidotes/protectants |
| Bridion | Sugammadex | 04/29/2024 | 92:12 - Antidotes | 91:04.28 - Neuromuscular blocking agent antidote |
| Pedmark | Sodium Thiosulfate | 04/29/2024 | 92:56 - Protective Agents | 91:04.12 - Chemotherapy antidotes/protectants |
| Nithiodote | Sodium Thiosulfate | 04/29/2024 | 92:12 - Antidotes | 91:04.24 - Cyanide antidotes; 84:04.08.92 - Antifungals, Miscellaneous |
| Nithiodote | Sodium Nitrite | 04/29/2024 | 92:12 - Antidotes | 91:04.24 - Cyanide antidotes |
| ATNAA Auto-Injector; DuoDote Auto-Injector; Protopam | Pralidoxime | 04/29/2024 | 92:12 - Antidotes | 91:04.20 - Organophosphate antidote |
| Elmiron | Pentosan | 04/29/2024 | 92:56 - Protective Agents | 91:04.12 - Chemotherapy antidotes/protectants |
| Methylene Blue | 04/29/2024 | 92:12 - Antidotes | 91:04.16 - Methemoglobinemia antidote | |
| Mesnex | Mesna | 04/29/2024 | 92:56 - Protective Agents | 91:04.12 - Chemotherapy antidotes/protectants |
| Fusilev; Khapzory | LEVOleucovorin | 04/29/2024 | 92:12 - Antidotes | 91:04.12 - Chemotherapy antidotes/protectants |
| Leucovorin | 04/29/2024 | 92:12 - Antidotes | 91:04.12 - Chemotherapy antidotes/protectants | |
| Voraxaze | Glucarpidase | 04/29/2024 | 92:12 - Antidotes | 91:04.12 - Chemotherapy antidotes/protectants; 44:00 - Enzymes |
| Antabuse | Disulfiram | 04/29/2024 | 92:04 - Alcohol Deterrents | 91:02 - Alcohol Deterrents |
| Totect; Zinecard | Dexrazoxane | 04/29/2024 | 92:56 - Protective Agents | 91:04.12 - Chemotherapy antidotes/protectants |
| Ethyol | Amifostine | 04/29/2024 | 92:56 - Protective Agents | 91:04.12 - Chemotherapy antidotes/protectants |
| Campral | Acamprosate | 04/29/2024 | 28:92 - Central Nervous System Agents, Miscellaneous | 91:02 - Alcohol Deterrents |
| Zilbrysq | Zilucoplan | 04/29/2024 | 92:32.08 - Complement Inhibitors | 90:08.08 - Complement Inhibitors |
| Lupkynis | Voclosporin | 04/29/2024 | 92:44 - Immunosuppressive Agents | 90:24.08 - T-cell Blockers |
| Entyvio | Vedolizumab | 04/29/2024 | 56:44 - Immunomodulatory Agents | 90:24.92 - Disease-modifying Antirheumatic Drugs, Miscellaneous |
| Stelara | Ustekinumab | 04/29/2024 | 92:36 - Disease-modifying Antirheumatic Drugs; 92:20 - Immunomodulatory Agents; 84:92 - Skin and Mucous Membrane Agents, Miscellaneous; 56:92 - GI Drugs, Miscellaneous | 90:24.20.92 - Interleukin-mediated Agents, Miscellaneous |
| Briumvi | Ublituximab | 04/29/2024 | 92:20 - Immunomodulatory Agents | 90:04.04 - Monoclonal Antibodies |
| Xeljanz | Tofacitinib | 04/29/2024 | 92:36 - Disease-modifying Antirheumatic Drugs; 92:20 - Immunomodulatory Agents | 90:24.12.92 - Janus Kinase Inhibitors, Miscellaneous |
| Actemra | Tocilizumab | 04/29/2024 | 92:36 - Disease-modifying Antirheumatic Drugs; 92:20 - Immunomodulatory Agents | 90:24.20.92 - Interleukin-mediated Agents, Miscellaneous |
| Aubagio | Teriflunomide | 04/29/2024 | 92:20 - Immunomodulatory Agents | 90:04.20 - Antimetabolites |
| Astagraf; Envarsus; Prograf | Tacrolimus | 04/29/2024 | 92:44 - Immunosuppressive Agents | 90:28.28.92 - Calcineurin Inhibitors, Miscellaneous |
| Enjaymo | Sutimlimab-jome | 04/29/2024 | 92:32.08 - Complement Inhibitors | 90:20 - Complement Inhibitor Agents |
| Rapamune | Sirolimus | 04/29/2024 | 92:44 - Immunosuppressive Agents | 90:28.24.92 - mTOR Inhibitors, Miscellaneous; 84:06.28 - Immunomodulatory Agents |
| Mayzent | Siponimod | 04/29/2024 | 92:20 - Immunomodulatory Agents | 90:04.16 - Sphingosine 1-Phosphate (S1P) Agents |
| Cosentyx | Secukinumab | 04/29/2024 | 92:36 - Disease-modifying Antirheumatic Drugs; 84:92 - Skin and Mucous Membrane Agents, Miscellaneous | 90:24.20.92 - Interleukin-mediated Agents, Miscellaneous |
| Enspryng | Satralizumab | 04/29/2024 | 92:20 - Immunomodulatory Agents | 90:12.04 - Monoclonal Antibodies |
| Kevzara | Sarilumab | 04/29/2024 | 92:36 - Disease-modifying Antirheumatic Drugs | 90:24.20.92 - Interleukin-mediated Agents, Miscellaneous |
| Rystiggo | Rozanolixizumab | 04/29/2024 | 92:20 - Immunomodulatory Agents | 90:08.04 - Neonatal Fc Receptor Blockers |
| Evenity | Romosozumab | 04/29/2024 | 92:22 - Bone Anabolic Agents | 90:16 - Bone-modifying Agents |
| Ultomiris | Ravulizumab | 04/29/2024 | 92:32.08 - Complement Inhibitors | 90:20 - Complement Inhibitor Agents |
| Ponvory | Ponesimod | 04/29/2024 | 92:20 - Immunomodulatory Agents | 90:04.16 - Sphingosine 1-Phosphate (S1P) Agents |
| Plegridy | Peginterferon Beta-1a | 04/29/2024 | 92:20 - Immunomodulatory Agents | 90:04.12 - Interferons |
| Empaveli | Pegcetacoplan | 04/29/2024 | 92:32.08 - Complement Inhibitors | 90:20 - Complement Inhibitor Agents |
| Zeposia | Ozanimod Hydrochloride | 04/29/2024 | 92:20 - Immunomodulatory Agents | 90:04.16 - Sphingosine 1-Phosphate (S1P) Agents |
| Xolair | Omalizumab | 04/29/2024 | 48:92 - Respiratory Tract Agents, Miscellaneous | 90:28.16.92 - Interleukin Inhibitor Agents, Miscellaneous |
| Kesimpta | Ofatumumab | 04/29/2024 | 92:20 - Immunomodulatory Agents | 90:04.04 - Monoclonal Antibodies |
| Ocrevus | Ocrelizumab | 04/29/2024 | 92:20 - Immunomodulatory Agents | 90:04.04 - Monoclonal Antibodies |
| Tysabri | Natalizumab | 04/29/2024 | 92:20 - Immunomodulatory Agents | 90:04.04 - Monoclonal Antibodies |
| CellCept; Myfortic | Mycophenolate | 04/29/2024 | 92:44 - Immunosuppressive Agents | 90:28.08.92 - Antimetabolites, Immunosuppressive Therapy, Miscellaneous |
| Arava | Leflunomide | 04/29/2024 | 92:36 - Disease-modifying Antirheumatic Drugs; 92:20 - Immunomodulatory Agents | 90:24.04 - Monocarboxylic Acid Amide Agents |
| Leqembi | Lecanemab | 04/29/2024 | 28:92 - Central Nervous System Agents, Miscellaneous | 90:10.04 - Monoclonal Antibodies |
| Taltz | Ixekizumab | 04/29/2024 | 92:36 - Disease-modifying Antirheumatic Drugs; 84:92 - Skin and Mucous Membrane Agents, Miscellaneous | 90:24.20.92 - Interleukin-mediated Agents, Miscellaneous |
| Fabhalta | Iptacopan | 04/29/2024 | 92:32.08 - Complement Inhibitors | 90:20 - Complement Inhibitor Agents |
| Avonex; Extavia; Betaseron; Rebif | Interferon Beta | 04/29/2024 | 92:20 - Immunomodulatory Agents | 90:04.12 - Interferons |
| Avsola; Inflectra; Remicade; Remsima; Renflexis | inFLIXimab | 04/29/2024 | 92:36 - Disease-modifying Antirheumatic Drugs | 90:24.16.92 - Tumor Necrosis Factor Inhibitors, Miscellaneous |
| Uplinza | Inebilizumab | 04/29/2024 | 92:20 - Immunomodulatory Agents | 90:12.04 - Monoclonal Antibodies |
| Simponi | Golimumab | 04/29/2024 | 92:36 - Disease-modifying Antirheumatic Drugs; 92:20 - Immunomodulatory Agents; 56:92 - GI Drugs, Miscellaneous | 90:24.16.92 - Tumor Necrosis Factor Inhibitors, Miscellaneous |
| Copaxone; Glatopa | Glatiramer | 04/29/2024 | 92:20 - Immunomodulatory Agents | 90:04.24 - Amino Acid Polymers |
| Gilenya | Fingolimod | 04/29/2024 | 92:20 - Immunomodulatory Agents | 90:04.16 - Sphingosine 1-Phosphate (S1P) Agents |
| Enbrel; Erelzi; Eticovo | Etanercept | 04/29/2024 | 92:36 - Disease-modifying Antirheumatic Drugs | 90:24.16.92 - Tumor Necrosis Factor Inhibitors, Miscellaneous |
| Gamifant | Emapalumab | 04/29/2024 | 92:44 - Immunosuppressive Agents | 90:28.20.92 - Interferon Gamma Inhibitor Agents, Miscellaneous |
| Vyvgart | Efgartigimod alfa-fcab | 04/29/2024 | 92:20 - Immunomodulatory Agents | 90:08.04 - Neonatal Fc Receptor Blockers |
| Soliris | Eculizumab | 04/29/2024 | 92:32.08 - Complement Inhibitors | 90:20 - Complement Inhibitor Agents |
| Vumerity | Diroximel Fumarate | 04/29/2024 | 92:20 - Immunomodulatory Agents | 90:04.08 - Fumarates |
| Bafiertam; Tecfidera | Dimethyl Fumarate; Monomethyl Fumarate | 04/29/2024 | 92:20 - Immunomodulatory Agents | 90:04.08 - Fumarates |
| Prolia; Xgeva | Denosumab | 04/29/2024 | 92:24 - Bone Resorption Inhibitors | 90:16 - Bone-modifying Agents |
| Gengraf; Neoral; SandIMMUNE | cycloSPORINE | 04/29/2024 | 92:44 - Immunosuppressive Agents; 92:36 - Disease-modifying Antirheumatic Drugs; 92:20 - Immunomodulatory Agents | 90:28.28.92 - Calcineurin Inhibitors, Miscellaneous |
| Mavenclad | Cladribine | 04/29/2024 | 92:20 - Immunomodulatory Agents | 90:04.20 - Antimetabolites; 10:00 - Antineoplastic Agents |
| Cimzia | Certolizumab | 04/29/2024 | 92:36 - Disease-modifying Antirheumatic Drugs; 92:20 - Immunomodulatory Agents; 56:92 - GI Drugs, Miscellaneous | 90:24.16.92 - Tumor Necrosis Factor Inhibitors, Miscellaneous |
| Benlysta | Belimumab | 04/29/2024 | 92:44 - Immunosuppressive Agents | 90:24.28 - IgG1 Monoclonal Antibodies |
| Nulojix | Belatacept | 04/29/2024 | 92:44 - Immunosuppressive Agents | 90:28.12.92 - T-cell Costimulatory Blockers, Miscellaneous |
| Simulect | Basiliximab | 04/29/2024 | 92:44 - Immunosuppressive Agents | 90:28.16.92 - Interleukin Inhibitor Agents, Miscellaneous |
| Olumiant | Baricitinib | 04/29/2024 | 92:36 - Disease-modifying Antirheumatic Drugs | 90:24.12.92 - Janus Kinase Inhibitors, Miscellaneous |
| Azasan; Imuran | azaTHIOprine | 04/29/2024 | 92:44 - Immunosuppressive Agents; 92:36 - Disease-modifying Antirheumatic Drugs; 92:20 - Immunomodulatory Agents | 90:28.08.92 - Antimetabolites, Immunosuppressive Therapy, Miscellaneous |
| Tavneos | Avacopan | 04/29/2024 | 92:32.08 - Complement Inhibitors | 90:20 - Complement Inhibitor Agents |
| Otezla | Apremilast | 04/29/2024 | 92:36 - Disease-modifying Antirheumatic Drugs; 92:20 - Immunomodulatory Agents; 84:92 - Skin and Mucous Membrane Agents, Miscellaneous | 90:24.24.92 - Phosphodiesterase-4 Inhibitors, Miscellaneous; 92:20 - Immunomodulatory Agents; 84:92 - Skin and Mucous Membrane Agents, Miscellaneous |
| Thymoglobulin | Antithymocyte Globulin (Rabbit) | 04/29/2024 | 92:44 - Immunosuppressive Agents | 90:28.04.92 - Polyclonal Antibodies, Miscellaneous |
| Atgam | Antithymocyte Globulin (Equine) | 04/29/2024 | 92:44 - Immunosuppressive Agents | 90:28.04.92 - Polyclonal Antibodies, Miscellaneous |
| Saphnelo | Anifrolumab-fnia | 04/29/2024 | 92:44 - Immunosuppressive Agents | 90:24.28 - IgG1 Monoclonal Antibodies |
| Kineret | Anakinra | 04/29/2024 | 92:36 - Disease-modifying Antirheumatic Drugs; 92:20 - Immunomodulatory Agents | 90:24.20.92 - Interleukin-mediated Agents, Miscellaneous |
| Lemtrada | Alemtuzumab | 04/29/2024 | 92:20 - Immunomodulatory Agents | 90:04.04 - Monoclonal Antibodies |
| Aduhelm | Aducanumab-avwa | 04/29/2024 | 28:92 - Central Nervous System Agents, Miscellaneous | 90:10.04 - Monoclonal Antibodies |
| Abrilada; Amjevita; Cyltezo; Hadlima; Hulio; Humira; Hyrimoz | Adalimumab | 04/29/2024 | 92:36 - Disease-modifying Antirheumatic Drugs; 92:20 - Immunomodulatory Agents; 56:92 - GI Drugs, Miscellaneous | 90:24.16.92 - Tumor Necrosis Factor Inhibitors, Miscellaneous |
| Gordochom | Undecylenic Acid | 04/29/2024 | 84:04.08.92 - Antifungals, Miscellaneous | 84:04.16 - Astringents, Anti-infective |
| Klisyri | Tirbanibulin | 04/29/2024 | 84:92 - Skin and Mucous Membrane Agents, Miscellaneous | 84:18 - Antiproliferants |
| Aklief | Trifarotene | 04/29/2024 | 84:92 - Skin and Mucous Membrane Agents, Miscellaneous | 84:28 - Keratolytic Agents |
| Arazlo; Avage; Duobrii; Fabior; Tazorac | Tazarotene | 04/29/2024 | 84:92 - Skin and Mucous Membrane Agents, Miscellaneous | 84:28 - Keratolytic Agents |
| Vtama | Tapinarof | 04/29/2024 | 84:06.92 - Anti-inflammatory Agents, Miscellaneous | 84:24.12 - Basic Ointments and Protectants |
| Versiclear | Sodium Thiosulfate | 04/29/2024 | 84:04.08.92 - Antifungals, Miscellaneous | 84:04.08.92 - Antifungals, Miscellaneous; 91:04.24 - Cyanide antidotes |
| Veregen | Sinecatechins | 04/29/2024 | 84:92 - Skin and Mucous Membrane Agents, Miscellaneous | 84:28 - Keratolytic Agents |
| SSD; Thermazene | Silver Sulfadiazine | 04/29/2024 | 84:04.92 - Local Anti-infectives, Miscellaneous | 84:04.16 - Astringents, Anti-infective |
| Selsun | Selenium Sulfide | 04/29/2024 | 84:04.92 - Local Anti-infectives, Miscellaneous | 84:04.16 - Astringents, Anti-infective |
| Opzelura | Ruxolitinib Phosphate | 04/29/2024 | 84:92 - Skin and Mucous Membrane Agents, Miscellaneous | 84:06.16 - Janus Kinase Inhibitors |
| Litfulo | Ritlecitinib | 04/29/2024 | 84:92 - Skin and Mucous Membrane Agents, Miscellaneous | 84:06.16 - Janus Kinase Inhibitors |
| Podocon-25 | Podophyllum Resin | 04/29/2024 | 84:92 - Skin and Mucous Membrane Agents, Miscellaneous | 84:28 - Keratolytic Agents |
| Condylox | Podofilox | 04/29/2024 | 84:92 - Skin and Mucous Membrane Agents, Miscellaneous | 84:28 - Keratolytic Agents |
| Elidel | Pimecrolimus | 04/29/2024 | 84:06.28 - Immunomodulatory Agents; 92:44 - Immunosuppressive Agents | 84:06.28 - Immunomodulatory Agents |
| Rhofade | Oxymetazoline | 04/29/2024 | 84:92 - Skin and Mucous Membrane Agents, Miscellaneous | 84:06.24 - Adrenergic Agonists; 52:32 - Vasoconstrictors |
| Rectiv | Nitroglycerin | 04/29/2024 | 84:92 - Skin and Mucous Membrane Agents, Miscellaneous | 84:24.12 - Basic Ointments and Protectants |
| Valchlor | Mechlorethamine | 04/29/2024 | 84:92 - Skin and Mucous Membrane Agents, Miscellaneous | 84:18 - Antiproliferants |
| Sulfamylon | Mafenide | 04/29/2024 | 84:04.92 - Local Anti-infectives, Miscellaneous | 84:04.04 - Antibacterials |
| Endari | L-Glutamine | 04/29/2024 | 92:92 - Other Miscellaneous Therapeutic Agents | |
| Absorica; Amnesteem; Claravis; Myorisan; Sotret; Zenatane | ISOtretinoin | 04/29/2024 | 84:92 - Skin and Mucous Membrane Agents, Miscellaneous | 84:28 - Keratolytic Agents |
| Vytone | Iodoquinol | 04/29/2024 | 84:04.92 - Local Anti-infectives, Miscellaneous | 84:04.16 - Astringents, Anti-infective |
| Iodine | 04/29/2024 | 84:04.92 - Local Anti-infectives, Miscellaneous | 84:04.16 - Astringents, Anti-infective | |
| Aldara | Imiquimod | 04/29/2024 | 84:92 - Skin and Mucous Membrane Agents, Miscellaneous | 84:18 - Antiproliferants |
| Qbrexza | Glycopyrronium | 04/29/2024 | 84:92 - Skin and Mucous Membrane Agents, Miscellaneous | 84:12 - Astringents |
| Gentian Violet | 04/29/2024 | 84:04.08.92 - Antifungals, Miscellaneous | 84:04.16 - Astringents, Anti-infective | |
| Carac; Efudex; Fluroplex | Fluorouracil | 04/29/2024 | 84:92 - Skin and Mucous Membrane Agents, Miscellaneous | 84:18 - Antiproliferants; 10:00 - Antineoplastic Agents |
| Propecia | Finasteride | 04/29/2024 | 84:92 - Skin and Mucous Membrane Agents, Miscellaneous | 84:16 - Cell Stimulants and Proliferants; 92:04 - 5-alpha-Reductase Inhibitors |
| Artiss; Evarrest; Evicel; Raplixa; TachoSil; Tisseel | Fibrin Sealant (Human) | 04/29/2024 | 84:92 - Skin and Mucous Membrane Agents, Miscellaneous | 84:24.12 - Basic Ointments and Protectants |
| Oracea | Doxycycline | 04/29/2024 | 84:92 - Skin and Mucous Membrane Agents, Miscellaneous | 84:04.04 - Antibacterials; 8:12.24 - Tetracyclines; 8:30.08 - Antimalarials; 52:04.04 - Antibacterials |
| Korsuva | Difelikefalin | 04/29/2024 | 84:92 - Skin and Mucous Membrane Agents, Miscellaneous | 84:08 - Antipruritics and Local Anesthetics |
| Debrisan | Dextranomer | 04/29/2024 | 84:92 - Skin and Mucous Membrane Agents, Miscellaneous | 84:24 - Emollients, Demulcents, and Protectants |
| Sotyktu | Deucravacitinib | 04/29/2024 | 84:92 - Skin and Mucous Membrane Agents, Miscellaneous | 84:06.16 - Janus Kinase Inhibitors |
| Eucrisa | Crisaborole | 04/29/2024 | 84:06.92 - Anti-inflammatory Agents, Miscellaneous | 84:06.12 - Phosphodiesterase-4 Inhibitors |
| N/A | Collagenase | 04/29/2024 | 84:92 - Skin and Mucous Membrane Agents, Miscellaneous; 44:00 - Enzymes | 84:24.12 - Basic Ointments and Protectants; 44:00 - Enzymes |
| Winlevi | Clascoterone | 04/29/2024 | 84:92 - Skin and Mucous Membrane Agents, Miscellaneous | 84:06.92 - Anti-inflammatory Agents, Miscellaneous |
| Betasept; Biopatch | Chlorhexidine | 04/29/2024 | 84:04.92 - Local Anti-infectives, Miscellaneous | 84:04.16 - Astringents, Anti-infective; 8:30.04 - Amebicides; 52:04.24 - Astringents |
| Dovonex; Taclonex | Calcipotriene | 04/29/2024 | 84:92 - Skin and Mucous Membrane Agents, Miscellaneous | 84:24.12 - Basic Ointments and Protectants |
| Mirvaso | Brimonidine | 04/29/2024 | 84:92 - Skin and Mucous Membrane Agents, Miscellaneous | 84:06.24 - Adrenergic Agonists; 52:40.04 - alpha-Adrenergic Agonists |
| Boric Acid | 04/29/2024 | 84:04.92 - Local Anti-infectives, Miscellaneous | 84:04.16 - Astringents, Anti-infective | |
| Targretin | Bexarotene | 04/29/2024 | 84:92 - Skin and Mucous Membrane Agents, Miscellaneous | 84:18 - Antiproliferants; 10:00 - Antineoplastic Agents |
| Zephiran | Benzalkonium | 04/29/2024 | 84:04.92 - Local Anti-infectives, Miscellaneous | 84:04.16 - Astringents, Anti-infective |
| Azelex; Finacea | Azelaic Acid | 04/29/2024 | 84:92 - Skin and Mucous Membrane Agents, Miscellaneous | 84:04.04 - Antibacterials |
| NexoBrid | Anacaulase | 04/29/2024 | 84:92 - Skin and Mucous Membrane Agents, Miscellaneous | 84:28 - Keratolytic Agents; 44:00 - Enzymes |
| Levulan Kerastick | Aminolevulinic Acid | 04/29/2024 | 84:92 - Skin and Mucous Membrane Agents, Miscellaneous | 84:18 - Antiproliferants |
| Panretin | Alitretinoin | 04/29/2024 | 84:92 - Skin and Mucous Membrane Agents, Miscellaneous | 84:18 - Antiproliferants |
| Differin | Adapalene | 04/29/2024 | 84:92 - Skin and Mucous Membrane Agents, Miscellaneous | 84:28 - Keratolytic Agents; 92:56 - Protective Agents |
| Soriatane | Acitretin | 04/29/2024 | 84:92 - Skin and Mucous Membrane Agents, Miscellaneous | 84:28 - Keratolytic Agents |
| Cibinqo | Abrocitinib | 04/29/2024 | 84:92 - Skin and Mucous Membrane Agents, Miscellaneous | 84:06.16 - Janus Kinase Inhibitors; 90:24.12.92 - Janus Kinase Inhibitors, Miscellaneous |
| Isturisa | Osilodrostat | 04/25/2024 | 92:92 - Other Miscellaneous Therapeutic Agents | 68:04 - Adrenals |
| Gattex | Teduglutide | 04/25/2024 | 56:92 - GI Drugs, Miscellaneous | 56:16 - Digestants |
| Trulance | Plecanatide | 04/25/2024 | 56:92 - GI Drugs, Miscellaneous | 56:18.12 - Guanylate Cyclase C (GCC) Receptor Agonists |
| Bylvay | Odevixibat | 04/25/2024 | 56:92 - GI Drugs, Miscellaneous | 56:14 - Cholelitholytic Agents |
| Ocaliva | Obeticholic Acid | 04/25/2024 | 56:92 - GI Drugs, Miscellaneous | 56:14 - Cholelitholytic Agents |
| Movantik | Naloxegol | 04/25/2024 | 56:92 - GI Drugs, Miscellaneous | 56:18.04 - Opioid Antagonists |
| Symproic | Naldemedine | 04/25/2024 | 56:92 - GI Drugs, Miscellaneous | 56:18.04 - Opioid Antagonists |
| Cesamet | Nabilone | 04/25/2024 | 56:22.92 - Antiemetics, Miscellaneous | 56:22.24 - Cannabinoids |
| Relistor | Methylnaltrexone | 04/25/2024 | 56:92 - GI Drugs, Miscellaneous | 56:18.04 - Opioid Antagonists |
| Livmarli | Maralixibat | 04/25/2024 | 56:92 - GI Drugs, Miscellaneous | 56:14 - Cholelitholytic Agents |
| Amitiza | Lubiprostone | 04/25/2024 | 56:92 - GI Drugs, Miscellaneous | 56:18.08 - Chloride Channel Activators |
| Linzess | Linaclotide | 04/25/2024 | 56:92 - GI Drugs, Miscellaneous | 56:18.12 - Guanylate Cyclase C (GCC) Receptor Agonists |
| Fecal Microbiota, Live – jslm | 04/25/2024 | 92:92 - Other Miscellaneous Therapeutic Agents | 56:92 - GI Drugs, Miscellaneous | |
| Vowst | Fecal microbiota spores, live-brpk | 04/25/2024 | 92:92 - Other Miscellaneous Therapeutic Agents | 56:92 - GI Drugs, Miscellaneous |
| Viberzi | Eluxadoline | 04/25/2024 | 56:92 - GI Drugs, Miscellaneous | 56:08 - Antidiarrhea Agents |
| Inapsine | Droperidol | 04/25/2024 | 28:24.92 - Anxiolytics, Sedatives, and Hypnotics; Miscellaneous | 56:22.12 - Dopamine Receptor Antagonists |
| Marinol | Dronabinol | 04/25/2024 | 56:22.92 - Antiemetics, Miscellaneous | 56:92 - GI Drugs, Miscellaneous |
| Cholbam | Cholic Acid | 04/25/2024 | 56:92 - GI Drugs, Miscellaneous | 56:14 - Cholelitholytic Agents |
| Barhemsys | Amisulpride | 04/25/2024 | 56:22.92 - Antiemetics, Miscellaneous | 56:22.12 - Dopamine Receptor Antagonists |
| Entereg | Alvimopan | 04/25/2024 | 56:92 - GI Drugs, Miscellaneous | 56:18.04 - Opioid Antagonists |
| Tezspire | Tezepelumab-ekko | 04/25/2024 | 48:92 - Respiratory Tract Agents, Miscellaneous | 48:10.20 - Interleukin Antagonists |
| Arcalyst | Rilonacept | 04/25/2024 | 92:92 - Other Miscellaneous Therapeutic Agents | 48:10.20 - Interleukin Antagonists |
| Ventavis | Iloprost | 04/25/2024 | 48:48.28 - Prostacyclin and prostacyclin derivatives; 24:12.92 - Vasodilating Agents, Miscellaneous | 48:48.28 - Prostacyclin and prostacyclin derivatives |
| Fluorides | 04/25/2024 | 92:28 - Cariostatic Agents | 34:00 - Dental Agents | |
| Andexxa | Factor Xa (recombinant), inactivated | 04/25/2024 | 20:28.92 - Antihemorrhagic Agents, Miscellaneous | 20:28.16 - Hemostatics |
| Targretin | Bexarotene | 04/25/2024 | 10:00 - Antineoplastic Agents | 10:00 - Antineoplastic Agents; 84:18 - Antiproliferants |
| Amantadine | 03/28/2024 | 8:18.04 - Adamantanes | 8:18.04 - Adamantanes; 28:36.04 - Adamantanes; 12:08.04 - Antiparkinsonian Agents | |
| Aranesp | Darbepoetin Alfa | 03/28/2024 | 20:16 - Hematopoietic Agents | 20:16 - Hematopoietic Agents; 20:04 - Antianemia Drugs |
| Col-Probenecid | Probenecid | 03/28/2024 | 40:40 - Uricosuric Agents | 40:40 - Uricosuric Agents; 92:16 - Antigout Agents |
| Fosrenol | Lanthanum | 03/28/2024 | 40:18.19 - Phosphate-reducing Agents; 92:12 - Antidotes | 40:18.19 - Phosphate-reducing Agents |
| Yodoxin | Iodoquinol | 03/28/2024 | 8:30.04 - Amebicides | 8:30.04 - Amebicides; 84:04.92 - Local Anti-infectives, Miscellaneous |
| Nizoral | Ketoconazole | 03/28/2024 | 8:14.08 - Azoles | 8:14.08 - Azoles; 84:04.08.08 - Azoles |
| LamISIL | Terbinafine | 03/28/2024 | 8:14.04 - Allylamines | 8:14.04 - Allylamines; 84:04.08.04 - Allylamines |
| Zovirax | Acyclovir | 03/28/2024 | 8:18.32 - Nucleosides and Nucleotides | 8:18.32 - Nucleosides and Nucleotides; 84:04.06 - Antivirals |
| Pylera; Sumycin | Tetracycline | 03/28/2024 | 8:12.24 - Tetracyclines; 8:30.08 - Antimalarials | 8:12.24 - Tetracyclines; 8:30.08 - Antimalarials; 52:04.04 - Antibacterials; 84:04.04 - Antibacterials |
| Flagyl | metroNIDAZOLE | 03/28/2024 | 8:30.16.92 - Nitroimidazole Derivatives, Miscellaneous; 8:30.04 - Amebicides; 56:28 - Antiulcer Agents and Acid Suppressants | 8:30.16.92 - Nitroimidazole Derivatives, Miscellaneous; 8:30.04 - Amebicides; 56:28 - Antiulcer Agents and Acid Suppressants; 84:04.04 - Antibacterials; 84:92 - Skin and Mucous Membrane Agents, Miscellaneous |
| Cleocin HCl | Clindamycin | 03/28/2024 | 8:12.28.20 - Lincomycins | 8:12.28.20 - Lincomycins; 84:04.04 - Antibacterials |
| Lidocaine | 03/28/2024 | 24:04.04.08 - Class Ib Antiarrhythmics | 24:04.04.08 - Class Ib Antiarrhythmics; 72:00 - Local Anesthetics; 84:08 - Antipruritics and Local Anesthetics | |
| Amoxil | Amoxicillin | 03/28/2024 | 8:12.16.08 - Aminopenicillins; 56:28 - Antiulcer Agents and Acid Suppressants | 8:12.16.08 - Aminopenicillins; 56:28 - Antiulcer Agents and Acid Suppressants; 56:28.18 - Potassium-competitive Acid Blockers |
| Alvesco | Ciclesonide | 03/28/2024 | 68:04 - Adrenals | 68:04 - Adrenals; 52:08.08 - Corticosteroids |
| Cytovene | Ganciclovir | 03/28/2024 | 8:18.32 - Nucleosides and Nucleotides | 8:18.32 - Nucleosides and Nucleotides; 52:04.20 - Antivirals |
| Poly-Rx | Polymyxin B | 03/28/2024 | 8:12.28.28 - Polymyxins; 84:04.04 - Antibacterials | 8:12.28.28 - Polymyxins; 84:04.04 - Antibacterials; 52:04.04 - Antibacterials |
| Ofloxacin | 03/28/2024 | 8:12.18 - Quinolones | 8:12.18 - Quinolones; 52:04.04 - Antibacterials | |
| Avelox | Moxifloxacin | 03/28/2024 | 8:12.18 - Quinolones; 8:16.04 - Antituberculosis Agents | 8:12.18 - Quinolones; 8:16.04 - Antituberculosis Agents; 52:04.04 - Antibacterials; 84:04.04 - Antibacterials |
| Levaquin | levoFLOXacin | 03/28/2024 | 8:12.18 - Quinolones; 8:16.04 - Antituberculosis Agents | 8:12.18 - Quinolones; 8:16.04 - Antituberculosis Agents; 52:04.04 - Antibacterials; 84:04.04 - Antibacterials |
| Doryx; Monodox | Doxycycline | 03/28/2024 | 8:12.24 - Tetracyclines; 8:30.08 - Antimalarials | 8:12.24 - Tetracyclines; 8:30.08 - Antimalarials; 52:04.04 - Antibacterials; 84:04.04 - Antibacterials |
| Cetraxal | Ciprofloxacin | 03/28/2024 | 52:04.04 - Antibacterials | 52:04.04 - Antibacterials; 8:12.18 - Quinolones |
| Cipro | Ciprofloxacin | 03/28/2024 | 8:12.18 - Quinolones; 8:16.04 - Antituberculosis Agents | 8:12.18 - Quinolones; 8:16.04 - Antituberculosis Agents; 52:04.04 - Antibacterials |
| Adcirca | Tadalafil | 03/28/2024 | 48:48.24 - Phosphodiesterase Type 5 Inhibitors | 48:48.24 - Phosphodiesterase Type 5 Inhibitors; 24:08.12 - Phosphodiesterase Type 5 Inhibitors |
| AlyQ; Cialis | Tadalafil | 03/28/2024 | 24:12.12 - Phosphodiesterase Type 5 Inhibitors | 24:08.12 - Phosphodiesterase Type 5 Inhibitors; 48:48.24 - Phosphodiesterase Type 5 Inhibitors |
| Kuvan | Sapropterin | 03/28/2024 | 92:92 - Other Miscellaneous Therapeutic Agents | 44:08 - Enzyme Cofactors/Chaperones |
| Galafold | Migalastat | 03/28/2024 | 92:92 - Other Miscellaneous Therapeutic Agents | 44:08 - Enzyme Cofactors/Chaperones |
| Orfadin | Nitisinone | 03/28/2024 | 92:92 - Other Miscellaneous Therapeutic Agents | 44:04 - Enzyme Inhibitors |
| Opfolda | Miglustat | 03/28/2024 | 92:92 - Other Miscellaneous Therapeutic Agents | 44:04 - Enzyme Inhibitors |
| Zavesca | Miglustat | 03/28/2024 | 92:92 - Other Miscellaneous Therapeutic Agents | 44:04 - Enzyme Inhibitors |
| Zokinvy | Lonafarnib | 03/28/2024 | 92:92 - Other Miscellaneous Therapeutic Agents | 44:04 - Enzyme Inhibitors |
| Cerdelga | Eliglustat | 03/28/2024 | 92:92 - Other Miscellaneous Therapeutic Agents | 44:04 - Enzyme Inhibitors |
| Sodium Chloride | 03/27/2024 | 40:12 - Replacement Preparations | 40:12 - Replacement Preparations; 40:36 - Irrigating Solutions | |
| Takhzyro | Lanadelumab | 03/27/2024 | 92:32.12 - Kallikrein Inhibitors | 24:48.08 - Kallikrein Inhibitors |
| Kalbitor | Ecallantide | 03/27/2024 | 92:32.12 - Kallikrein Inhibitors | 24:48.08 - Kallikrein Inhibitors |
| Orladeyo | Berotralstat | 03/27/2024 | 92:32.12 - Kallikrein Inhibitors | 24:48.08 - Kallikrein Inhibitors |
| Firazyr | Icatibant | 03/27/2024 | 92:32.04 - Bradykinin Receptor Antagonists | 92:32.04 - Bradykinin Receptor Antagonists; 24:48.04 - Bradykinin Receptor Antagonists |
| Gloperba; Colcrys; Mitigare | Colchicine | 03/27/2024 | 92:16 - Antigout Agents | 24:44 - Cardiovascular Drugs, Nonsteroidal Anti-inflammatory; 92:16 - Antigout Agents |
| Zaroxolyn | metOLazone | 03/27/2024 | 24:08.24.24 - Thiazide-like Diuretics | 40:28.24 - Thiazide-like Diuretics; 24:36.24 - Thiazide-like Diuretics |
| Clorpres; Tenoretic; Thalitone | chlorthalidone | 03/27/2024 | 24:08.24.24 - Thiazide-like Diuretics | 40:28.24 - Thiazide-like Diuretics; 24:36.24 - Thiazide-like Diuretics |
| Accuretic; Amturnide; Avalide | hydroCHLOROthiazide | 03/27/2024 | 24:08.24.20 - Thiazide Diuretics | 40:28.20 - Thiazide Diuretics; 24:36.20 - Thiazide Diuretics |
| Diuril | Chlorothiazide | 03/27/2024 | 24:08.24.20 - Thiazide Diuretics | 40:28.20 - Thiazide Diuretics; 24:36.20 - Thiazide Diuretics |
| Dyazide; Dyrenium; Maxzide | Triamterene | 03/27/2024 | 24:08.24.16 - Potassium-sparing Diuretics | 40:28.16 - Potassium-sparing Diuretics; 24:36.16 - Potassium-sparing Diuretics |
| N/A | aMILoride | 03/27/2024 | 24:08.24.16 - Potassium-sparing Diuretics | 40:28.16 - Potassium-sparing Diuretics; 24:36.16 - Potassium-sparing Diuretics |
| Osmitrol | Mannitol | 03/27/2024 | 24:08.24.12 - Osmotic Diuretics | 40:28.12 - Osmotic Diuretics; 24:36.12 - Osmotic Diuretics |
| Demadex | Torsemide | 03/27/2024 | 40:28.08 - Loop Diuretics; 24:08.24.08 - Loop Diuretics | 40:28.08 - Loop Diuretics; 24:36.08 - Loop Diuretics |
| Lasix | Furosemide | 03/27/2024 | 40:28.08 - Loop Diuretics; 24:08.24.08 - Loop Diuretics | 40:28.08 - Loop Diuretics; 24:36.08 - Loop Diuretics |
| Edecrin | Ethacrynic Acid | 03/27/2024 | 40:28.08 - Loop Diuretics; 24:08.24.08 - Loop Diuretics | 40:28.08 - Loop Diuretics; 24:36.08 - Loop Diuretics |
| n/a | Bumetanide | 03/27/2024 | 40:28.08 - Loop Diuretics; 24:08.24.08 - Loop Diuretics | 40:28.08 - Loop Diuretics; 24:36.08 - Loop Diuretics |
| Entresto | Sacubitril and Valsartan | 03/27/2024 | 24:32.92 - Renin-Angiotensin-Aldosterone System Inhibitors, Miscellaneous | 24:32.12 - Angiotensin II Receptor Antagonists/Neprolysin Inhibitors |
| Methyldopa | 03/27/2024 | 24:08.16 - Central alpha-Agonists | 24:24 - Central alpha-Agonists | |
| Intuniv; Tenex | guanFACINE | 03/27/2024 | 24:08.16 - Central alpha-Agonists | 24:24 - Central alpha-Agonists |
| Catapres | cloNIDine | 03/27/2024 | 24:08.16 - Central alpha-Agonists | 24:24 - Central alpha-Agonists |
| Inderal LA; Innopran XL | Propranolol | 03/27/2024 | 24:24 - beta-Adrenergic Blocking Agents; 24:04.04.16 - Class II Antiarrhythmics; 12:16.08.04 - Non-selective beta-Adrenergic Blocking Agents; 28:32.92 - Antimigraine Agents, Miscellaneous | 24:20 - beta-Adrenergic Blocking Agents; 24:04.04.16 - Class II Antiarrhythmics; 12:16.08.04 - Non-selective beta-Adrenergic Blocking Agents; 28:32.92 - Antimigraine Agents, Miscellaneous |
| Lopressor; Toprol XL | Metoprolol | 03/27/2024 | 24:24 - beta-Adrenergic Blocking Agents; 24:04.04.16 - Class II Antiarrhythmics; 12:16.08.08 - Selective beta-Adrenergic Blocking Agents; 24:08.92 - Vasodilating Agents, Miscellaneous | 24:20 - beta-Adrenergic Blocking Agents; 24:04.04.16 - Class II Antiarrhythmics; 12:16.08.08 - Selective beta-Adrenergic Blocking Agents |
| Brevibloc | Esmolol | 03/27/2024 | 24:24 - beta-Adrenergic Blocking Agents; 24:04.04.16 - Class II Antiarrhythmics; 12:16.08.08 - Selective beta-Adrenergic Blocking Agents; 24:08.92 - Vasodilating Agents, Miscellaneous | 24:20 - beta-Adrenergic Blocking Agents; 24:04.04.16 - Class II Antiarrhythmics; 12:16.08.08 - Selective beta-Adrenergic Blocking Agents |
| Zebeta | Bisoprolol | 03/27/2024 | 24:24 - beta-Adrenergic Blocking Agents; 24:04.04.16 - Class II Antiarrhythmics; 12:16.08.08 - Selective beta-Adrenergic Blocking Agents; 24:08.92 - Vasodilating Agents, Miscellaneous | 24:20 - beta-Adrenergic Blocking Agents; 24:04.04.16 - Class II Antiarrhythmics; 12:16.08.08 - Selective beta-Adrenergic Blocking Agents |
| Pletal | Cilostazol | 03/27/2024 | 24:12.12 - Phosphodiesterase Type 5 Inhibitors | 20:12.18 - Platelet-aggregation Inhibitors |
| Sclerosol Intrapleural Aerosol | Talc | 03/27/2024 | 24:16 - Sclerosing Agents | 24:12 - Sclerosing Agents |
| Sotradecol | Sodium Tetradecyl Sulfate | 03/27/2024 | 24:16 - Sclerosing Agents | 24:12 - Sclerosing Agents |
| Asclera | Polidocanol | 03/27/2024 | 24:16 - Sclerosing Agents | 24:12 - Sclerosing Agents |
| Ablysinol | Dehydrated Alcohol | 03/27/2024 | 24:16 - Sclerosing Agents | 24:12 - Sclerosing Agents |
| Betimol | Timolol | 03/27/2024 | 24:24 - beta-Adrenergic Blocking Agents; 24:08.92 - Vasodilating Agents, Miscellaneous; 24:04.04.16 - Class II Antiarrhythmics; 12:16.08.04 - Non-selective beta-Adrenergic Blocking Agents; 28:32.92 - Antimigraine Agents, Miscellaneous; | 24:20 - beta-Adrenergic Blocking Agents; 24:04.04.16 - Class II Antiarrhythmics; 12:16.08.04 - Non-selective beta-Adrenergic Blocking Agents; 28:32.92 - Antimigraine Agents, Miscellaneous; 52:40.08 - beta-Adrenergic Blocking Agents |
| N/A | Terazosin | 03/27/2024 | 24:20 - Sclerosing Agents; 24:08.92 - Vasodilating Agents, Miscellaneous | 24:16 - Sclerosing Agents |
| Minipress | Prazosin | 03/27/2024 | 24:20 - Sclerosing Agents; 24:08.92 - Vasodilating Agents, Miscellaneous | 24:16 - Sclerosing Agents |
| n/a | Pindolol | 03/27/2024 | 24:24 - beta-Adrenergic Blocking Agents; 24:04.04.16 - Class II Antiarrhythmics; 12:16.08.04 - Non-selective beta-Adrenergic Blocking Agents; 24:08.92 - Vasodilating Agents, Miscellaneous | 24:20 - beta-Adrenergic Blocking Agents; 24:04.04.16 - Class II Antiarrhythmics; 12:16.08.04 - Non-selective beta-Adrenergic Blocking Agents |
| Cardura | Doxazosin | 03/27/2024 | 24:20 - Sclerosing Agents; 24:08.92 - Vasodilating Agents, Miscellaneous | 24:16 - Sclerosing Agents |
| Coreg | Carvedilol | 03/25/2024 | 24:24; 24:04.04.16 - Class II Antiarrhythmics; 12:16.04.12 - Selective alpha-1-Adrenergic Blocking Agents; 12:16.08.04 - Non-selective beta-Adrenergic Blocking Agents; 24:20 - Sclerosing Agents; 24:08.92 - Vasodilating Agents, Miscellaneous | 24:20 - beta-Adrenergic Blocking Agents; 24:04.04.16 - Class II Antiarrhythmics; 12:16.04.12 - Selective alpha-1-Adrenergic Blocking Agents; 12:16.08.04 - Non-selective beta-Adrenergic Blocking Agents; 24:16 - Sclerosing Agents |
| n/a | Betaxolol | 03/25/2024 | 24:24 - beta-Adrenergic Blocking Agents; 24:04.04.16 - Class II Antiarrhythmics; 12:16.08.08 - Selective beta-Adrenergic Blocking Agents; 24:08.92 - Vasodilating Agents, Miscellaneous | 24:20 - beta-Adrenergic Blocking Agents; 24:04.04.16 - Class II Antiarrhythmics; 12:16.08.08 - Selective beta-Adrenergic Blocking Agents; 52:40.08 - beta-Adrenergic Blocking Agents |
| Sectral | Acebutolol | 03/25/2024 | 24:24 - beta-Adrenergic Blocking Agents; 24:04.04.16 - Class II Antiarrhythmics; 12:16.08.08 - Selective beta-Adrenergic Blocking Agents; 24:08.92 - Vasodilating Agents, Miscellaneous | 24:20 - beta-Adrenergic Blocking Agents; 24:04.04.16 - Class II Antiarrhythmics; 12:16.08.08 - Selective beta-Adrenergic Blocking Agents |
| Minoxidil | 03/25/2024 | 24:08.20 - Direct Vasodilators | 24:08.16 - Direct Vasodilators; 84:16 - Cell Stimulants and Proliferants | |
| BiDil | hydrALAZINE | 03/25/2024 | 24:08.20 - Direct Vasodilators | 24:08.16 - Direct Vasodilators |
| Nitropress | Sodium Nitroprusside | 03/25/2024 | 24:08.20 - Direct Vasodilators | 24:08.16 - Direct Vasodilators |
| Para-Time SR | Papaverine | 03/25/2024 | 24:08.20 - Direct Vasodilators | 24:08.16 - Direct Vasodilators |
| Corlopam | Fenoldopam | 03/25/2024 | 24:08.20 - Direct Vasodilators | 24:08.16 - Direct Vasodilators |
| Caverject; Edex; Muse | Alprostadil | 03/25/2024 | 24:12.92 - Vasodilating Agents, Miscellaneous | 24:08.16 - Direct Vasodilators |
| Calan | Verapamil | 03/25/2024 | 24:08.12.92 - Calcium-Channel Blocking Agents, Miscellaneous | 24:04.04.24 - Class IV Antiarrhythmics |
| Cardizem | dilTIAZem | 03/25/2024 | 24:08.12.92 - Calcium-Channel Blocking Agents, Miscellaneous | 24:04.04.24 - Class IV Antiarrhythmics; 24:28 - Calcium-Channel Blocking Agents |
| Levitra | Vardenafil | 03/25/2024 | 24:12.12 - Phosphodiesterase Type 5 Inhibitors | 24:08.12 - Phosphodiesterase Type 5 Inhibitors |
| Revatio; Viagra | Sildenafil | 03/25/2024 | 24:12.12 - Phosphodiesterase Type 5 Inhibitors | 24:08.12 - Phosphodiesterase Type 5 Inhibitors |
| Stendra | Avanafil | 03/25/2024 | 24:12.12 - Phosphodiesterase Type 5 Inhibitors | 24:08.12 - Phosphodiesterase Type 5 Inhibitors |
| Verquvo | Vericiguat | 03/25/2024 | 24:12.92 - Vasodilating Agents, Miscellaneous | 24:08.10 - cGMP Synthesis Agent |
| Genosyl; INOmax | Nitric Oxide | 03/25/2024 | 24:12.08 - Nitrates and Nitrites | 24:08.08 - Nitrates and Nitrites |
| Tenormin | Atenolol | 03/25/2024 | 24:24 - beta-Adrenergic Blocking Agents; 24:04.04.16 - Class II Antiarrhythmics; 12:16.08.08 - Selective beta-Adrenergic Blocking Agents; 24:08.92 - Vasodilating Agents, Miscellaneous24:12.08 - Nitrates and Nitrites | 24:20 - beta-Adrenergic Blocking Agents; 24:04.04.16 - Class II Antiarrhythmics; 12:16.08.08 - Selective beta-Adrenergic Blocking Agents |
| Rectiv | Nitroglycerin | 03/25/2024 | 24:12.08 - Nitrates and Nitrites | 24:08.08 - Nitrates and Nitrites; 84:92 - Skin and Mucous Membrane Agents, Miscellaneous |
| Imdur; BiDil; Monoket | Isosorbide | 03/25/2024 | 24:12.08 - Nitrates and Nitrites | 24:08.08 - Nitrates and Nitrites |
| Amyl Nitrite | 03/25/2024 | 24:12.08 - Nitrates and Nitrites | 24:08.08 - Nitrates and Nitrites | |
| N/A | Labetalol | 03/25/2024 | 24:20 - beta-Adrenergic Blocking Agents; 24:16 - alpha-Adrenergic Blocking Agents; 24:04.04.16 - Class II Antiarrhythmics; 12:16.04.12 - Selective alpha-1-Adrenergic Blocking Agents; 12:16.08.04 - Non-selective beta-Adrenergic Blocking Agents; 24:08.04 - | 24:20 - beta-Adrenergic Blocking Agents; 24:16 - alpha-Adrenergic Blocking Agents; 24:04.04.16 - Class II Antiarrhythmics; 12:16.04.12 - Selective alpha-1-Adrenergic Blocking Agents; 12:16.08.04 - Non-selective beta-Adrenergic Blocking Agents |
| Juxtapid | Lomitapide | 03/25/2024 | 24:06.92 - Antilipemic Agents, Miscellaneous | 24:06.22 - Microsomal Triglyceride Transfer Protein (MTP) Inhibitors |
| Evkeeza | Evinacumab-dgnb | 03/25/2024 | 24:06.92 - Antilipemic Agents, Miscellaneous | 24:06.20 - ANGPTL3 Inhibitors |
| Lovaza; Omtryg | Omega-3-acid Ethyl Esters | 03/25/2024 | 24:06.92 - Antilipemic Agents, Miscellaneous | 24:06.12 - Omega-3-mediated Antilipemics |
| Vascepa | Icosapent Ethyl | 03/25/2024 | 24:06.92 - Antilipemic Agents, Miscellaneous | 24:06.12 - Omega-3-mediated Antilipemics |
| Nexletol; Nexlizet | Bempedoic Acid | 03/25/2024 | 24:06.92 - Antilipemic Agents, Miscellaneous | 24:06.07 - ACL Inhibitors |
| Corlanor | Ivabradine | 03/25/2024 | 24:04.92 - Cardiac Drugs, Miscellaneous | 24:04.08 - Cardiotonic Agents |
| Digitek; Lanoxin | Digoxin | 03/25/2024 | 24:04.08 - Cardiotonic Agents; 24:04.04.92 - Antiarrhythmics, Miscellaneous | 24:04.08 - Cardiotonic Agents |
| Calan; Tarka; Verelan | Verapamil | 03/25/2024 | 24:28.92 - Calcium-Channel Blocking Agents, Miscellaneous; 24:04.04.24 - Class IV Antiarrhythmics; 24:08.12.92 - Calcium-Channel Blocking Agents, Miscellaneous; 24:12.92 - Vasodilating Agents, Miscellaneous | 24:04.04.24 - Class IV Antiarrhythmics; 24:28 - Calcium-Channel Blocking Agents |
| Cardizem | dilTIAZem | 03/25/2024 | 24:28.92 - Calcium-Channel Blocking Agents, Miscellaneous; 24:04.04.24 - Class IV Antiarrhythmics; 24:08.12.92 - Calcium-Channel Blocking Agents, Miscellaneous; 24:12.92 - Vasodilating Agents, Miscellaneous | 24:04.04.24 - Class IV Antiarrhythmics; 24:28 - Calcium-Channel Blocking Agents |
| Betapace; Sorine | Sotalol | 03/25/2024 | 24:20 - beta-Adrenergic Blocking Agents; 24:04.04.20 - Class III Antiarrhythmics; 24:04.04.16 - Class II Antiarrhythmics; 12:16.08.04 - Non-selective beta-Adrenergic Blocking Agents | 24:20 - beta-Adrenergic Blocking Agents; 24:04.04.20 - Class III Antiarrhythmics; 12:16.08.04 - Non-selective beta-Adrenergic Blocking Agents |
| Aggrenox | Dipyridamole | 03/25/2024 | 36:18 - Cardiac Function | 36:18 - Cardiac Function; 20:12.18 - Platelet-aggregation Inhibitors |
| Bystolic | Nebivolol | 03/25/2024 | 24:20 - beta-Adrenergic Blocking Agents | 24:20 - beta-Adrenergic Blocking Agents; 24:04.04.16 - Class II Antiarrhythmics; 12:16.08.04 - Non-selective beta-Adrenergic Blocking Agents |
| Defitelio | Defibrotide Sodium | 03/25/2024 | 20:12.92 - Antithrombotic Agents, Miscellaneous | 20:12.10 - von Willebrand Factor-related Antithrombotics |
| Cablivi | Caplacizumab | 03/25/2024 | 20:12.92 - Antithrombotic Agents, Miscellaneous | 20:12.10 - von Willebrand Factor-related Antithrombotics |
| Thrombate III | Antithrombin III | 03/25/2024 | 20:12.04.92 - Anticoagulants, Miscellaneous | 20:12.04.20 - Antithrombin Replacements |
| ATryn | Antithrombin alfa | 03/25/2024 | 20:12.04.92 - Anticoagulants, Miscellaneous | 20:12.04.20 - Antithrombin Replacements |
| Arixtra | Fondaparinux | 03/25/2024 | 20:12.04.92 - Anticoagulants, Miscellaneous | 20:12.04.15 - Indirect Factor Xa Inhibitors |
| Corgard | Nadolol | 03/25/2024 | 24:24 - beta-Adrenergic Blocking Agents; 24:04.04.16 - Class II Antiarrhythmics; 12:16.08.08 - Selective beta-Adrenergic Blocking Agents; 24:08.92 - Vasodilating Agents, Miscellaneous | 24:20 - beta-Adrenergic Blocking Agents; 12:16.08.08 - Selective beta-Adrenergic Blocking Agents; 24:04.04.16 - Class II Antiarrhythmics |
| Descovy | Emtricitabine and Tenofovir Alafenamide | 03/25/2024 | 8:18.08.20 - HIV Nucleoside and Nucleotide Reverse Transcriptase Inhibitors | 8:18.08.20 - HIV Nucleoside and Nucleotide Reverse Transcriptase Inhibitors; 8:18.32 - Nucleosides and Nucleotides |
| Alinia | Nitazoxanide | 03/25/2024 | 8:30.92 - Antiprotozoals, Miscellaneous | 8:30.20 - Antiprotozoals, Cryptosporidiosis |
| metroNIDAZOLE | 03/25/2024 | 8:30.92 - Antiprotozoals, Miscellaneous | 8:30.16.92 - Nitroimidazole Derivatives, Miscellaneous | |
| Impavido | Miltefosine | 03/25/2024 | 8:30.92 - Antiprotozoals, Miscellaneous | 8:30.16.08 - Nitroimidazole Derivatives, Anti-leishmanial |
| Fexinidazole | 03/25/2024 | 8:30.92 - Antiprotozoals, Miscellaneous | 8:30.16.04 - Nitroimidazole Derivatives, Trypanocidal | |
| Benznidazole | 03/25/2024 | 8:30.92 - Antiprotozoals, Miscellaneous | 8:30.16.04 - Nitroimidazole Derivatives, Trypanocidal | |
| Tindamax | Tinidazole | 03/25/2024 | 8:30.92 - Antiprotozoals, Miscellaneous | 8:30.16 - Antiprotozoals, Nitroimidazole-derivative |
| Solosec | Secnidazole | 03/25/2024 | 8:30.92 - Antiprotozoals, Miscellaneous | 8:30.16 - Antiprotozoals, Nitroimidazole-derivative |
| NebuPent | Pentamidine | 03/25/2024 | 8:30.92 - Antiprotozoals, Miscellaneous | 8:30.12 - Antiprotozoals, Pneumocystis jirovecii Pneumonia |
| Mepron | Atovaquone | 03/25/2024 | 8:30.92 - Antiprotozoals, Miscellaneous | 8:30.12 - Antiprotozoals, Pneumocystis jirovecii Pneumonia |
| Paxlovid | Nirmatrelvir and Ritonavir | 03/25/2024 | 8:18.92 - Antivirals, Miscellaneous | 8:18.48 - Coronavirus (COVID-19) |
| Livtencity | Maribavir | 03/25/2024 | 8:18.92 - Antivirals, Miscellaneous | 8:18.44 - CMV Antivirals |
| Prevymis | Letermovir | 03/25/2024 | 8:18.92 - Antivirals, Miscellaneous | 8:18.44 - CMV Antivirals |
| Mavyret | Glecaprevir And Pibrentasvir | 03/25/2024 | 8:18.40.20 - HCV Protease Inhibitors | 8:18.40.20 - HCV Protease Inhibitors; 8:18.40.24 - HCV Replication Complex Inhibitors |
| Zepatier | Elbasvir and Grazoprevir | 03/25/2024 | 8:18.40.24 - HCV Replication Complex Inhibitors | 8:18.40.24 - HCV Replication Complex Inhibitors; 8:18.40.20 - HCV Protease Inhibitors |
| Xofluza | Baloxavir | 03/25/2024 | 8:18.92 - Antivirals, Miscellaneous | 8:18.30 - Endonuclease Inhibitors |
| Pegasys | Peginterferon Alfa | 03/25/2024 | 8:18.20 - Interferons | 8:18.20 - Interferons; 92:20 - Immunomodulatory Agents; 10:00 - Antineoplastic Agents |
| Tybost | Cobicistat | 03/25/2024 | 92:92 - Other Miscellaneous Therapeutic Agents | 8:18.08.92 - Antiretrovirals, Miscellaneous |
| Lamprene | Clofazimine | 03/25/2024 | 8:16.92 - Antimycobacterials, Miscellaneous | 8:16.08 - Antileprosy Agents |
| Brexafemme | Ibrexafungerp | 03/25/2024 | 8:14.92 - Antifungals, Miscellaneous | 8:14.20 - Triterpenoids |
| Orphenadrine | 02/27/2024 | 12:20.92 - Skeletal Muscle Relaxants, Miscellaneous | 12:20.10 - Indirect-acting Skeletal Muscle Relaxants | |
| Varenicline | 02/27/2024 | 12:92 - Autonomic Drugs, Miscellaneous | 12:02 - Smoking Cessation Agents | |
| Nicotine | 02/27/2024 | 12:92 - Autonomic Drugs, Miscellaneous | 12:02 - Smoking Cessation Agents | |
| Siliq | Brodalumab | 02/27/2024 | 84:92 - Skin and Mucous Membrane Agents, Miscellaneous | 84:06.28 - Immunomodulatory Agents |
| Tremfya | Guselkumab | 02/27/2024 | 84:92 - Skin and Mucous Membrane Agents, Miscellaneous | 84:06.28 - Immunomodulatory Agents |
| Elidel | Pimecrolimus | 02/27/2024 | 84:92 - Skin and Mucous Membrane Agents, Miscellaneous | 84:06.28 - Immunomodulatory Agents |
| Skyrizi | Risankizumab-rzaa | 02/27/2024 | 84:92 - Skin and Mucous Membrane Agents, Miscellaneous | 84:06.28 - Immunomodulatory Agents |
| Rapamune | Sirolimus | 02/27/2024 | 84:92 - Skin and Mucous Membrane Agents, Miscellaneous | 84:06.28 - Immunomodulatory Agents |
| Spevigo | Spesolimab-sbzo | 02/27/2024 | 84:92 - Skin and Mucous Membrane Agents, Miscellaneous | 84:06.28 - Immunomodulatory Agents |
| Protopic | Tacrolimus | 02/27/2024 | 84:92 - Skin and Mucous Membrane Agents, Miscellaneous | 84:06.28 - Immunomodulatory Agents |
| Ilumya | Tildrakizumab-asmn | 02/27/2024 | 84:92 - Skin and Mucous Membrane Agents, Miscellaneous | 84:06.28 - Immunomodulatory Agents |
| Adbry | Tralokinumab-ldrm | 02/27/2024 | 84:92 - Skin and Mucous Membrane Agents, Miscellaneous | 84:06.28 - Immunomodulatory Agents |
| Bimzelx | Bimekizumab-bkzx | 02/27/2024 | 84:92 - Skin and Mucous Membrane Agents, Miscellaneous | 84:06.28 - Immunomodulatory Agents |
| Filspari | Sparsentan | 02/27/2024 | 92:92 - Other Miscellaneous Therapeutic Agents | 48:48.12 - Endothelin receptor antagonists |
| Bethkis; Kitabis; Tobi | Tobramycin | 02/27/2024 | 8:12.02 - Aminoglycosides | 8:12.02 - Aminoglycosides; 52:04.04 - Antibacterials |
| Vyndamax; Vyndaqel | Tafamidis | 02/27/2024 | 92:92 - Other Miscellaneous Therapeutic Agents | 24:04.92 - Cardiac Drugs, Miscellaneous |
| Neo-Fradin; Neo-Rx Powder | Neomycin | 02/27/2024 | 8:12.02 - Aminoglycosides | 8:12.02 - Aminoglycosides; 52:04.04 - Antibacterials; 84:04.04 - Antibacterials |
| Gentamicin | 02/27/2024 | 8:12.02 - Aminoglycosides | 8:12.02 - Aminoglycosides; 52:04.04 - Antibacterials; 84:04.04 - Antibacterials | |
| ERYC; Ery-Tab; PCE Dispertab | Erythromycin | 02/27/2024 | 8:12.12.04 - Erythromycins | 8:12.12.04 - Erythromycins; 52:04.04 - Antibacterials; 84:04.04 - Antibacterials |
| AtroPen Auto-Injector; Duodote | Atropine | 02/27/2024 | 12:08.08 - Antimuscarinics/Antispasmodics; 92:12 - Antidotes; 48:12.08 - Anticholinergic Agents | 12:08.08 - Antimuscarinics/Antispasmodics; 52:24 - Mydriatics; 91:00 - Antidote Therapeutics |
| Firdapse; Ruzurgi | Amifampridine | 02/27/2024 | 92:92 - Other Miscellaneous Therapeutic Agents | 12:04 - Parasympathomimetic (Cholinergic) Agents |
| Triprolidine | 02/23/2024 | 4:04 - First Generation Antihistamines ; 48:04.04 - First Generation Antihistamines; 4:04.20 - Propylamine Derivatives | 4:04 - First Generation Antihistamines; 48:04.04 - First Generation Antihistamines | |
| Loratadine | 02/23/2024 | 4:08 - Second Generation Antihistamines | 4:08 - Second Generation Antihistamines; 48:04.08 - Second Generation Antihistamines | |
| Levocetirizine | 02/23/2024 | 4:08 - Second Generation Antihistamines | 4:08 - Second Generation Antihistamines; 48:04.08 - Second Generation Antihistamines | |
| Fexofenadine | 02/23/2024 | 4:08 - Second Generation Antihistamines | 4:08 - Second Generation Antihistamines; 48:04.08 - Second Generation Antihistamines | |
| diphenhydrAMINE | 02/23/2024 | 4:04 - First Generation Antihistamines ; 48:04.04 - First Generation Antihistamines; 12:08.04 - Antiparkinsonian Agents; 28:24.92 - Anxiolytics, Sedatives, and Hypnotics; Miscellaneous; 28:36.08 - Anticholinergic Agents; 48:08 - Antitussives; 48:12.08 - A | 4:04 - First Generation Antihistamines; 48:04.04 - First Generation Antihistamines; 12:08.04 - Antiparkinsonian Agents; 28:24.92 - Anxiolytics, Sedatives, and Hypnotics; Miscellaneous; 28:36.08 - Anticholinergic Agents; 48:08 - Antitussives; 48:12.08 - Anticholinergic Agents; 84:08 - Antiprurit | |
| Desloratadine | 02/23/2024 | 4:08 - Second Generation Antihistamines | 4:08 - Second Generation Antihistamines; 48:04.08 - Second Generation Antihistamines | |
| Cyproheptadine | 02/23/2024 | 4:04 - First Generation Antihistamines ; 48:04.04 - First Generation Antihistamines; 4:04.92 - Miscellaneous Derivatives | 4:04 - First Generation Antihistamines; 48:04.04 - First Generation Antihistamines | |
| Dayhist Allergy; Tavist Allergy (formerly Tavist-1) | Clemastine | 02/23/2024 | 4:04 - First Generation Antihistamines ; 48:04.04 - First Generation Antihistamines; 4:04.04 - Ethanolamine Derivatives | 4:04 - First Generation Antihistamines; 48:04.04 - First Generation Antihistamines |
| Chlorpheniramine | 02/23/2024 | 4:04 - First Generation Antihistamines ; 48:04.04 - First Generation Antihistamines ; 4:04.20 - Propylamine Derivatives | 4:04 - First Generation Antihistamines; 48:04.04 - First Generation Antihistamines | |
| Arbinoxa; Palgic | Carbinoxamine | 02/23/2024 | 4:04 - First Generation Antihistamines ; 48:04.04 - First Generation Antihistamines; 4:04.04 - Ethanolamine Derivatives | 4:04 - First Generation Antihistamines; 48:04.04 - First Generation Antihistamines |
| Bromaline; Bromaline DM Elixir; Bromfed DM Cough Syrup; Children's Dimetapp Cold & Allergy; Children's Dimetapp Cold & Allergy; Children's Dimetapp Cold & Cough | Brompheniramine | 02/23/2024 | 4:04 - First Generation Antihistamines ; 48:04.04 - First Generation Antihistamines ; 4:04.20 - Propylamine Derivatives | 4:04 - First Generation Antihistamines; 48:04.04 - First Generation Antihistamines |
| Demser | metyroSINE | 02/22/2024 | 92:92 - Other Miscellaneous Therapeutic Agents | 36:64 - Pheochromocytoma |
| Carbol-Fuchsin Antigen Skin Test | 02/22/2024 | 84:04.08.92 - Antifungals, Miscellaneous | 36:32 - Fungi | |
| Aggrenox; Persantine | Dipyridamole | 02/22/2024 | 24:12.92 - Vasodilating Agents, Miscellaneous ; 20:12.18 - Platelet-aggregation Inhibitors | 36:18 - Cardiac Function |
| Aralast; Glassia; Prolastin; Zemaira | alpha1-Proteinase Inhibitor | 02/22/2024 | 48:92 - Respiratory Tract Agents, Miscellaneous | 16:00 - Blood Derivatives |